Ulcerative colitis, NAS

ULCERNAS

ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 K51.9
  • Cause of death: ICD-10 K51.9

2 out of 7 registries used, show all original rules.

6280

4. Check minimum number of events

None

6280

5. Include endpoints

None

6280

6. Filter based on genotype QC (FinnGen only)

6280

Control definitions (FinnGen only)

Control exclude
K11_ENERCOLNONINF

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K51
Name in latin
Colitis ulcerosa non specificata

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 36595 17795 18637
Only index persons 34114 16773 17341
Unadjusted period prevalence (%)
Whole population 0.51 0.51 0.52
Only index persons 0.64 0.62 0.66
Median age at first event (years)
Whole population 45.73 46.05 45.27
Only index persons 44.32 44.79 43.86

-FinnGen-

Key figures

All Female Male
Number of individuals 6280 3349 2931
Unadjusted period prevalence (%) 1.21 1.14 1.29
Median age at first event (years) 46.05 43.48 49.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5664
Matched controls
56642
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
81.1
323.0
531
72
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
323.0
487
*
UJF30
NOMESCO Finland
Ileoscopy through colon
20.1
323.0
2266
1816
K50.9
ICD-10 Finland
Crohn disease, unspecified
2122.9
323.0
707
*
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
323.0
376
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
47.9
323.0
900
222
K51.5
ICD-10 Finland
Left sided colitis
6035.7
323.0
2951
9
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
323.0
1037
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
4503599627370496.0
323.0
5571
14
D94
ICPC
Chronic enteritis/ulcerative colitis
208.7
323.0
425
22
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
323.0
2244
8472
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
1623.9
323.0
948
7
L01BB02
ATC
mercaptopurine; oral
219.7
323.0
591
30
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
9395.1
323.0
818
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
+∞
323.0
430
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
7834.4
323.0
700
*
K50.8
ICD-10 Finland
Other Crohn disease
+∞
323.0
718
*
UJF32
NOMESCO Finland
Coloscopy
23.8
323.0
4262
6414
A07EC02
ATC
mesalazine; oral, rectal
1046.8
323.0
4562
223
K51
ICD-10 Finland
Ulcerative colitis
1141.6
323.0
788
8
P01AB01
ATC
metronidazole; oral, rectal
3.4
323.0
3024
14157
H02AB07
ATC
prednisone; oral
6.2
323.0
1729
3745
K51.8
ICD-10 Finland
Other ulcerative colitis
2349.0
323.0
1373
8
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
323.0
4453
*
A07EA02
ATC
hydrocortisone; rectal
250.5
323.0
1787
104
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.6
323.0
2607
8791
J01MA02
ATC
ciprofloxacin; systemic
3.4
323.0
2932
13487
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
11.4
323.0
1425
1624
A07EA06
ATC
budesonide; oral, local oral
220.9
323.0
1869
126
L04AX01
ATC
azathioprine; systemic
76.3
323.0
2285
497
A07EA01
ATC
prednisolone; rectal
449.4
323.0
380
9
H02AB06
ATC
prednisolone; systemic
8.0
323.0
4384
16938
A07EC01
ATC
sulfasalazine; oral, rectal
8.9
323.0
1380
1969
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
323.0
1734
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
430.2
323.0
440
11
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
307.1
292
*
ZX120
NOMESCO Finland
Intravenous
5.2
291.1
1014
2291
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
53.4
280.0
337
67
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
244.5
233
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.3
244.1
1473
5398
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
242.4
231
*
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
231.6
237.8
244
11
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
2256.1
235.9
227
*
UJF92
NOMESCO Finland
Capsular endoscopy
15.3
232.1
396
277
L04AB04
ATC
adalimumab; parenteral
13.0
211.7
387
317
A07EC03
ATC
olsalazine; oral
+∞
205.4
196
*
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
204.4
195
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
199.2
2558
14479
A02BC02
ATC
pantoprazole; systemic
2.4
197.9
3729
25480
K83.0
ICD-10 Finland
Cholangitis
17.3
195.7
317
193
WX002
NOMESCO Finland
Sedation and analgesia
2.9
186.8
1351
5470
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
185.8
1475
6334
A06AC01
ATC
ispaghula (psylla seeds); oral
2.7
178.3
1525
6821
4AA12
NOMESCO Finland
NA
158.4
174.6
184
12
A05AA02
ATC
ursodeoxycholic acid; oral
12.5
171.7
319
269
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.6
166.0
857
2699
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
42.9
165.2
207
50
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.9
149.6
446
809
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
148.1
2231
13053
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
48.7
143.3
175
37
L04AD01
ATC
ciclosporin; systemic
9.1
140.9
309
357
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
140.2
134
*
4AB02
NOMESCO Finland
NA
64.5
139.9
163
26
A07DA03
ATC
loperamide; oral
6.3
133.2
375
630
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
12.2
129.6
243
208
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
128.6
686
2189
C10AC01
ATC
colestyramine; oral
8.4
127.9
294
367
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
125.3
926
3696
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.3
124.5
505
1273
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.0
122.3
319
482
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.0
122.1
813
3032
JFH10
NOMESCO Finland
Total colectomy and ileostomy
73.1
112.9
129
18
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.9
109.4
261
345
K92.1
ICD-10 Finland
Melaena
4.5
104.6
394
920
N02AX02
ATC
tramadol; systemic, rectal
1.9
103.6
2267
14765
K50
ICD-10 Finland
Crohn disease [regional enteritis]
268.0
103.1
105
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
101.6
427
1107
Z93.2
ICD-10 Finland
Ileostomy status
55.7
100.8
120
22
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
332.7
98.3
99
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.8
94.1
659
2511
H02AB09
ATC
hydrocortisone; systemic
6.2
93.5
263
439
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
923.2
93.1
91
*
1370
FHL
Colonoscopy, whole colon
33.7
92.7
122
37
JFF10
NOMESCO Finland
Loop enterostomy
24.3
91.4
131
55
A07AA09
ATC
vancomycin; oral
11.0
90.0
176
164
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
89.8
86
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
87.0
507
1706
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.1
84.1
347
882
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
83.5
80
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
82.3
765
3412
N02BE01
ATC
paracetamol; systemic, rectal
1.9
82.0
4619
39538
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.7
81.5
376
1054
A02BC03
ATC
lansoprazole; oral
1.9
81.3
1516
9132
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
63.7
80.8
94
15
3042
Kela drug reimbursment
NA
+∞
80.4
77
*
253
Kela drug reimbursment
NA
+∞
80.4
77
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.1
80.3
228
385
J01MA12
ATC
levofloxacin; systemic
2.1
79.3
1015
5262
K59.1
ICD-10 Finland
Functional diarrhoea
3.8
78.7
359
996
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
78.0
1197
6684
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.6
77.2
234
429
L04AC05
ATC
ustekinumab; parenteral
25.6
76.6
108
43
A02BC05
ATC
esomeprazole; systemic
1.7
75.0
2078
14180
A02BC01
ATC
omeprazole; systemic
1.9
73.2
1428
8685
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
72.6
821
4013
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
71.2
1485
9222
R50.9
ICD-10 Finland
Fever, unspecified
2.2
70.8
837
4171
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
70.6
426
1462
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
+∞
69.9
67
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
7.4
69.7
171
236
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
+∞
68.9
66
*
ZXE00
NOMESCO Finland
One hour or less
1.7
67.8
2127
14927
JF1BD
NOMESCO Finland
Very extensive small bowel CT
20.3
67.5
102
51
UJG02
NOMESCO Finland
Proctoscopy
6.1
67.4
190
318
K51.4
ICD-10 Finland
Inflammatory polyps
655.7
66.0
65
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
7.7
65.8
158
211
3AC01
NOMESCO Finland
NA
9.2
65.4
140
155
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
225.9
65.3
67
*
4AA33
NOMESCO Finland
NA
+∞
63.6
61
*
H02AB04
ATC
methylprednisolone; systemic
2.1
62.1
799
4111
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.1
61.8
174
291
K60.3
ICD-10 Finland
Anal fistula
5.7
61.7
183
327
L04AA01
ATC
[U] ciclosporin; systemic
6.7
61.3
162
249
L04AB06
ATC
golimumab; parenteral
9.0
61.0
132
149
C05AA08
ATC
fluocortolone; rectal, topical
2.1
60.3
782
4037
B01AB05
ATC
enoxaparin; parenteral
1.7
58.6
1420
9146
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.9
58.4
200
421
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.3
58.1
117
116
J01DB01
ATC
cefalexin; oral
1.7
56.7
4462
38982
TJF80
NOMESCO Finland
Ostomy education
9.9
55.6
114
117
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
55.4
2392
17958
JHA00
NOMESCO Finland
Anal or perianal incision
5.9
54.4
157
271
UJK02
NOMESCO Finland
ERCP
4.9
54.0
185
390
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
5.6
53.6
162
296
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
53.3
717
3741
WVA20
NOMESCO Finland
Medicine administration
5.0
53.2
179
370
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
20.3
53.1
80
40
ZXD05
NOMESCO Finland
Urgent procedure
1.6
52.7
1645
11323
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
52.2
1915
13741
6419
FHL
Other measure in this category
74.6
52.1
59
8
3005
Kela drug reimbursment
Tofacitinib
23.0
51.8
75
33
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
15.7
51.4
85
55
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
50.7
391
1558
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
50.3
421
1757
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
50.1
526
2460
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
50.1
48
*
K61.0
ICD-10 Finland
Anal abscess
5.1
49.8
162
323
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
11.1
49.7
96
88
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
49.4
1935
14067
JAH00
NOMESCO Finland
Laparotomy
4.2
48.9
193
470
JFF13
NOMESCO Finland
Terminal enterostomy
40.4
47.8
60
15
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.4
46.6
176
411
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
7.5
46.1
111
150
UJD02
NOMESCO Finland
Gastroscopy
3.0
46.0
287
1003
L04AA33
ATC
vedolizumab; parenteral
+∞
45.9
44
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
45.5
325
1237
UJF34
NOMESCO Finland
Left colonoscopy
10.5
45.5
90
87
Z2221
NOMESCO Finland
Medical doctor
1.6
45.2
1451
9984
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.1
44.8
259
860
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
21.9
44.4
65
30
M45
ICD-10 Finland
Ankylosing spondylitis
4.2
44.2
175
427
D11
ICPC
Diarrhoea
2.0
44.0
647
3482
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
118.4
43.8
47
*
JF1AD
NOMESCO Finland
Small bowel CT
16.9
43.7
70
42
E0000UV
ATC
NA
1.5
43.4
2018
15139
K56.7
ICD-10 Finland
Ileus, unspecified
5.6
43.1
130
238
UJK12
NOMESCO Finland
Peroral cholangioscopy
23.7
42.7
61
26
JFB00
NOMESCO Finland
Partial resection of small intestine
6.1
41.7
117
196
WX402
NOMESCO Finland
General anaesthesia
1.8
40.9
875
5350
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
40.8
1042
6712
5586X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]
+∞
40.7
39
*
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
13.0
40.5
72
56
N03AX16
ATC
pregabalin; oral
1.6
40.4
1106
7261
L04AA29
ATC
tofacitinib; oral
17.7
40.1
63
36
A06AC51
ATC
ispaghula, combinations; systemic
2.8
40.0
276
1029
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
40.0
873
5367
SPAT1263
SPAT
Sampling
1.5
40.0
2146
16529
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
39.7
336
1406
1490
FHL
Sigmoideoscopy (fiberscope)
24.6
39.7
56
23
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
39.5
313
1266
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
25.2
39.3
55
22
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.9
39.2
112
192
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
39.0
551
2911
M05BA04
ATC
alendronic acid; oral
2.5
38.9
333
1402
56902
ICD-8 Finland
Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)
+∞
38.6
37
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
38.4
481
2423
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
37.8
175
491
A03CA02
ATC
clidinium and psycholeptics; oral
2.6
37.3
282
1109
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
37.2
481
2454
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.5
37.2
179
519
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
37.1
1714
12732
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
36.9
365
1655
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
26.5
36.2
50
19
A02BA02
ATC
ranitidine; systemic
1.7
36.1
858
5394
UJH02
NOMESCO Finland
Anoscopy
2.8
35.5
235
853
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
+∞
35.4
34
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
35.3
412
2012
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
35.0
485
2543
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
34.8
985
6492
Z93
ICD-10 Finland
Artificial opening status
19.1
34.8
53
28
N05CF01
ATC
zopiclone; oral
1.5
34.6
1410
10155
R11
ICD-10 Finland
Nausea and vomiting
2.1
34.3
409
2017
B03BA03
ATC
hydroxocobalamin; parenteral
2.6
33.5
249
970
JGB40
NOMESCO Finland
Excision of rectum and end ileostomy
329.0
32.9
33
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
32.6
442
2295
E86
ICD-10 Finland
Volume depletion
4.1
31.9
128
318
SPAT1262
SPAT
Handing over of treatment supplies
1.7
31.6
815
5227
A07AA02
ATC
nystatin; oral
2.4
31.5
291
1273
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.6
31.4
236
925
K56.0
ICD-10 Finland
Paralytic ileus
7.1
31.2
77
109
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
31.2
1946
15226
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
25.5
30.9
43
17
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
30.7
365
1794
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
110.6
30.7
33
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
30.6
355
1725
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
14.2
30.6
52
37
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
30.3
358
1755
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
30.1
298
1349
D07AC01
ATC
betamethasone; topical
1.4
30.0
1582
11957
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
30.0
1062
7371
UJF02
NOMESCO Finland
Peroral enteroscopy
9.6
29.8
61
64
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
29.7
559
3259
SPAT1255
SPAT
Intravenous administration of medicine
2.2
29.7
318
1491
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.6
29.4
226
896
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.6
29.4
222
871
J02AC01
ATC
fluconazole; systemic
1.4
29.3
1895
14875
6410
FHL
Panprococolectomy and ileostomy
293.4
28.8
29
*
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
293.4
28.8
29
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
28.7
2033
16205
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
28.7
364
1840
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
21.1
28.6
42
20
UKC02
NOMESCO Finland
Cystoscopy
1.7
28.6
641
3942
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
28.6
744
4772
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.7
28.6
207
795
J01DA01
ATC
[U] cefalexin; systemic
1.4
28.5
3135
26912
N02AA05
ATC
oxycodone; systemic
1.8
28.4
557
3288
J01AA02
ATC
doxycycline; systemic
1.4
28.3
3841
34132
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
28.2
349
1743
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
28.1
1598
12227
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.8
28.1
95
200
JHD20
NOMESCO Finland
Incision of fistula-in-ano
5.4
27.8
85
160
K76.9
ICD-10 Finland
Liver disease, unspecified
4.5
27.7
100
225
D01
ICPC
Abdominal pain/cramps general
1.8
27.7
529
3096
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.9
27.5
117
308
R01AD08
ATC
fluticasone; nasal
1.4
27.1
1403
10529
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
26.9
1443
10897
D16
ICPC
Rectal bleeding
3.5
26.8
129
376
WX110
NOMESCO Finland
Local anesthesy
1.4
26.6
3585
31624
D18
ICPC
Change in faeces/bowel movements
3.6
26.6
123
347
R06.0
ICD-10 Finland
Dyspnoea
1.5
26.5
1032
7297
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
26.4
444
2491
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
26.4
255
1143
WW200
NOMESCO Finland
Immunization
2.9
26.3
166
587
JF2AB
NOMESCO Finland
Colongraphy with X-ray
13.7
26.2
45
33
Z94.4
ICD-10 Finland
Liver transplant status
11.0
25.7
49
45
R51.80
ICD-10 Finland
Headache
1.6
25.7
731
4793
J01FA10
ATC
azithromycin; systemic
1.3
25.5
3028
26093
R03AC02
ATC
salbutamol; inhalant
1.3
25.4
2559
21484
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
50.2
25.2
30
6
1380
FHL
Colonoscopy, left side
39.0
24.8
31
8
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
24.8
440
2515
D06BX01
ATC
metronidazole; topical
1.8
24.6
477
2804
Z3231
NOMESCO Finland
Registered nurse
1.4
24.4
1270
9503
JHD00
NOMESCO Finland
Anal dilatation
5.9
24.4
69
119
6525
FHL
Enterostomy occlusion
56.2
24.0
28
5
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.7
24.0
168
634
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
24.0
23
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
24.0
202
845
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
8.6
24.0
52
61
N06AX11
ATC
mirtazapine; oral
1.4
23.9
1442
11090
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
23.7
585
3690
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
23.6
1660
13101
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.6
23.6
173
671
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
23.5
803
5498
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
23.4
535
3301
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
23.3
163
613
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.4
23.3
70
130
J01FF01
ATC
clindamycin; systemic
1.4
23.3
1256
9453
S18
ICPC
Laceration/cut
1.4
23.1
1841
14825
5563A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis
+∞
22.9
22
*
J01CA04
ATC
amoxicillin; systemic
1.4
22.9
4299
39422
JJC00
NOMESCO Finland
Allogenic transplantation of liver
13.0
22.8
40
31
R10.0
ICD-10 Finland
Acute abdomen
2.7
22.8
164
629
D99
ICPC
Disease digestive system other
4.9
22.6
75
156
L88
ICD-10 Finland
Pyoderma gangrenosum
19.0
22.5
34
18
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
4.1
22.3
87
213
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
22.2
184
763
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
22.1
2261
18879
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.9
22.1
73
151
J01MA14
ATC
moxifloxacin; systemic
1.8
22.0
392
2243
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
+∞
21.9
21
*
D07AC13
ATC
mometasone; topical
1.4
21.8
1331
10226
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
21.7
602
3908
ZXC86
NOMESCO Finland
Use of endoscopic device
7.4
21.6
51
69
C05AA01
ATC
hydrocortisone; rectal, topical
2.1
21.4
241
1158
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
6.0
21.4
59
99
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
5.3
21.4
65
123
B81
ICPC
Anaemia vit B12/folate deficiency
2.6
21.3
155
597
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
21.2
222
1035
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
21.1
462
2815
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
21.1
1280
9817
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
21.0
387
2233
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.6
20.9
598
3913
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.4
20.9
76
174
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
20.9
753
5206
K74.3
ICD-10 Finland
Primary biliary cirrhosis
8.0
20.9
47
59
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.1
20.8
41
41
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
20.7
763
5301
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
20.7
163
660
JF1DM
NOMESCO Finland
Very extensive MRI of small bowel (more than 1.5 T)
210.7
20.6
21
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
20.5
686
4665
M25.5
ICD-10 Finland
Pain in joint
1.4
20.4
1295
9994
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
20.4
249
1236
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
11.2
20.4
38
34
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.5
20.4
160
646
SPAT1325
SPAT
Vaccination
1.4
20.2
1466
11568
D07XC01
ATC
betamethasone, combinations; topical
1.6
20.0
529
3391
N06AA09
ATC
amitriptyline; systemic
1.7
20.0
406
2419
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
19.9
215
1014
R01AD09
ATC
mometasone; nasal
1.3
19.9
2179
18288
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
35.9
19.8
25
7
D07AD01
ATC
clobetasol; topical
1.5
19.7
677
4627
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
19.7
999
7399
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.4
19.6
95
281
M54.5
ICD-10 Finland
Low back pain
1.3
19.5
1512
12045
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
12.1
19.5
35
29
C03CA01
ATC
furosemide; systemic
1.4
19.4
925
6771
J05AB01
ATC
aciclovir; systemic
1.4
19.2
921
6749
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
11.0
19.1
36
33
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
19.1
347
1996
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
8.9
19.0
40
45
K83.1
ICD-10 Finland
Obstruction of bile duct
4.3
19.0
70
163
R4190
NOMESCO Finland
Nutritional therapy
2.2
18.9
186
842
J01FA06
ATC
roxithromycin; oral
1.3
18.8
1818
14955
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
7.7
18.7
43
56
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
18.7
2526
21751
L04AA06
ATC
mycophenolic acid; systemic
3.1
18.7
105
346
RD210
NOMESCO Finland
NA
3.0
18.7
110
374
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.6
18.5
134
517
K30
ICD-10 Finland
Functional dyspepsia
1.7
18.4
443
2768
K61.1
ICD-10 Finland
Rectal abscess
9.1
18.3
38
42
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
18.3
1842
15230
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
18.2
153
641
A01AB09
ATC
miconazole; local oral
1.7
18.1
364
2163
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
5.0
18.0
58
118
WZC30
NOMESCO Finland
Teaching
1.6
17.9
552
3674
Z98.8
ICD-10 Finland
Other specified postsurgical states
3.8
17.9
77
207
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
15.3
17.9
29
19
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
17.9
357
2115
L88
ICPC
Rheumatoid/seropositive arthritis
2.2
17.8
175
792
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.2
17.7
188
882
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
3.7
17.7
77
209
6408
FHL
Colectomy and ileostomy
+∞
17.7
17
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
17.4
1271
9997
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.4
17.4
86
259
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
28.8
17.4
23
8
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
17.3
447
2847
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.0
17.3
100
337
SPAT1153
SPAT
Removal of sutures
1.3
17.2
1322
10477
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.6
17.2
78
220
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
17.1
643
4475
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
17.1
585
3990
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
17.1
1305
10338
WW500
NOMESCO Finland
Blood transfusion
2.2
17.1
173
796
J01FA09
ATC
clarithromycin; systemic
1.3
17.0
1488
12025
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
17.0
996
7553
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
8.6
16.9
36
42
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
16.8
845
6233
N05BA04
ATC
oxazepam; oral
1.4
16.7
1053
8079
5551A
ICD-9 Finland
Regional enteritis, Large intestine
+∞
16.7
16
*
5589X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis
+∞
16.7
16
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
8.8
16.6
35
40
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
9.2
16.6
34
37
SPAT1104
SPAT
Monitoring of emergency patient
1.8
16.6
274
1530
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.9
16.4
100
347
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
7.3
16.4
39
54
AA1AD
NOMESCO Finland
CT of head and brain
1.4
16.4
894
6690
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
16.3
709
5085
J01MA01
ATC
ofloxacin; systemic
1.7
16.3
349
2111
N03AX12
ATC
gabapentin; oral
1.5
16.2
624
4361
UJF30
SPAT
NA
6.5
16.1
41
63
E000001
ATC
NA
1.4
16.1
944
7158
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
16.0
468
3073
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.6
16.0
116
450
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
47.6
16.0
19
*
M03BX02
ATC
tizanidine; oral
1.3
16.0
3008
26793
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.2
15.9
157
715
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.0
15.9
50
100
E87.6
ICD-10 Finland
Hypokalaemia
2.5
15.8
125
508
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.9
15.8
97
340
SPAT1301
SPAT
No procedures
1.3
15.8
1350
10856
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
15.7
311
1836
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.0
15.7
196
986
K85
ICD-10 Finland
Acute pancreatitis
3.0
15.7
88
292
4AC05
NOMESCO Finland
NA
+∞
15.6
15
*
M09.1*K50.9
ICD-10 Finland
Juvenile arthritis in Crohn's disease [regional enteritis]
+∞
15.6
15
*
R53
ICD-10 Finland
Malaise and fatigue
1.4
15.6
844
6303
M79.6
ICD-10 Finland
Pain in limb
1.3
15.6
1545
12680
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
8.1
15.5
34
42
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
8.1
15.5
34
42
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
15.4
1294
10369
ZX112
NOMESCO Finland
Subcutaneous
2.8
15.4
101
371
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.5
15.3
123
506
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
6.5
15.3
39
60
K60.4
ICD-10 Finland
Rectal fistula
12.3
15.3
27
22
K29.7
ICD-10 Finland
Gastritis, unspecified
2.3
15.3
146
655
127
Kela drug reimbursment
Transplant complication
3.0
15.3
89
302
R01AD12
ATC
fluticasone furoate; nasal
1.3
15.2
1426
11605
M01AX17
ATC
nimesulide; oral
1.4
15.2
934
7124
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
6.2
15.1
40
65
B01AB10
ATC
tinzaparin; parenteral
1.8
15.1
270
1546
JJ5AT
NOMESCO Finland
NA
20.1
15.1
22
11
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
5.8
15.0
42
73
Z2446
NOMESCO Finland
Social worker
1.7
15.0
306
1827
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.7
14.9
103
390
N05CF02
ATC
zolpidem; oral
1.4
14.9
751
5535
K62.4
ICD-10 Finland
Stenosis of anus and rectum
8.9
14.9
31
35
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
14.9
3587
32762
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
14.9
1332
10765
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
3.3
14.9
75
231
SPAT1125
SPAT
Stoma care and guidance
3.9
14.9
61
159
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
14.8
280
1632
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.7
14.7
97
357
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
16.5
14.7
23
14
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
14.7
144
653
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.5
14.7
115
467
JN4BD
NOMESCO Finland
Extensive body CT
1.6
14.7
403
2606
Z43.2
ICD-10 Finland
Attention to ileostomy
13.2
14.7
25
19
K63.9
ICD-10 Finland
Disease of intestine, unspecified
6.8
14.6
36
53
S97
ICPC
Chronic ulcer skin
2.0
14.6
197
1024
B01AA03
ATC
warfarin; systemic
1.5
14.6
624
4454
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
+∞
14.6
14
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.9
14.6
60
157
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
14.5
284
1676
J05AB11
ATC
valaciclovir; oral
1.5
14.4
550
3834
JFA76
NOMESCO Finland
Closure of fistula of small intestine
36.1
14.4
18
5
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
9.4
14.4
29
31
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
14.4
444
2956
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
14.4
683
4978
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
14.4
315
1918
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.4
14.3
116
480
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
14.3
146
677
K02.1
ICD-10 Finland
Caries of dentine
1.2
14.2
2871
25622
B02.9
ICD-10 Finland
Zoster without complication
1.9
14.2
209
1121
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.4
14.2
51
118
A01AB04
ATC
amphotericin B; local oral
2.0
14.2
180
914
D29
ICPC
Digestive symptom/complaint other
2.7
14.1
93
344
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
14.0
2325
20278
G04CA02
ATC
tamsulosin; oral
1.4
13.9
758
5659
C07AB02
ATC
metoprolol; systemic
1.4
13.9
697
5128
H20.1
ICD-10 Finland
Chronic iridocyclitis
3.4
13.8
67
201
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
17.6
13.8
21
12
JFA56
NOMESCO Finland
Faecal microbiota transplantation
20.1
13.8
20
10
A07AA11
ATC
rifaximin; oral
11.4
13.8
25
22
-44
ICPC
Preventive immunization/medic
1.7
13.7
315
1944
A06AD11
ATC
lactulose; oral
1.5
13.7
488
3358
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
13.6
264
1550
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
13.6
1869
15927
A02BA04
ATC
nizatidine; systemic
1.7
13.6
279
1669
JGB61
NOMESCO Finland
Laparoscopic excision of rectum and ileoanal anastomosis
+∞
13.5
13
*
WX892
NOMESCO Finland
Monitored bed care
1.7
13.5
302
1847
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.8
13.5
234
1328
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
13.5
2590
22931
K90.0
ICD-10 Finland
Coeliac disease
2.2
13.5
135
619
SPAT1260
SPAT
Consultation of another employee
1.4
13.4
738
5514
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
9.3
13.4
27
29
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
13.4
1358
11139
Z3226
NOMESCO Finland
Physiotherapist
1.4
13.4
772
5818
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
25.8
13.3
18
7
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
13.3
2828
25302
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.6
13.3
96
374
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
13.3
144
686
S10
ICPC
Boil/carbuncle
1.8
13.3
230
1306
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
13.2
401
2660
H26.3
ICD-10 Finland
Drug-induced cataract
4.9
13.2
42
86
R35
ICD-10 Finland
Polyuria
1.8
13.1
236
1353
K65.0
ICD-10 Finland
Acute peritonitis
3.5
13.0
59
169
R52.9
ICD-10 Finland
Pain, unspecified
1.6
13.0
338
2157
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
12.9
372
2433
JGB96
NOMESCO Finland
Other proctectomy or excision of rectum
28.4
12.9
17
6
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
12.9
143
687
A46
ICD-10 Finland
Erysipelas
1.5
12.9
502
3515
C07AB07
ATC
bisoprolol; oral
1.3
12.8
1746
14844
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
12.8
493
3443
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
12.7
560
4016
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
12.7
1035
8228
A02BX02
ATC
sucralfate; oral
2.1
12.7
149
735
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
7.0
12.5
30
43
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.6
12.5
344
2226
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
12.5
333
2138
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
12.5
185
995
A03BA03
ATC
hyoscyamine; oral
3.9
12.4
49
125
E000006
ATC
NA
1.6
12.3
291
1813
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.7
12.3
53
146
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
12.2
456
3164
R15
ICD-10 Finland
Faecal incontinence
2.5
12.2
92
367
A28
ICPC
Limited function/disability NOS
1.5
12.2
444
3069
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
4.6
12.1
41
90
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
12.0
297
1870
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
12.0
187
1024
R02
ICPC
Shortness of breath/dyspnoea
1.5
12.0
446
3091
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
21.3
12.0
17
8
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
4.9
12.0
38
78
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
8.7
12.0
25
29
JN4AD
NOMESCO Finland
Body CT examination
1.7
11.9
258
1567
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.4
11.9
95
393
A03
ICPC
Fever
1.4
11.9
739
5634
R06AE07
ATC
cetirizine; oral
1.2
11.9
2052
17879
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
11.8
199
1118
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
11.8
121
561
R19.5
ICD-10 Finland
Other faecal abnormalities
3.0
11.8
65
215
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
11.8
386
2605
WX290
NOMESCO Finland
Other blockade of nerve
1.2
11.7
2222
19537
JG1JB
NOMESCO Finland
Defekography with X-ray
4.1
11.7
44
107
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.8
11.7
187
1034
SPAT1254
SPAT
Administration of medicine
1.4
11.7
566
4132
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
5.5
11.6
33
60
K55.1
ICD-10 Finland
Chronic vascular disorders of intestine
22.9
11.5
16
7
KMAK
NOMESCO Finland
NA
1.2
11.5
2546
22728
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.9
11.5
170
917
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
3.9
11.5
46
119
XKD00
NOMESCO Finland
Uroflowmetry
1.4
11.5
532
3854
N06AX21
ATC
duloxetine; oral
1.5
11.5
448
3138
5550A
ICD-9 Finland
Regional enteritis, Small intestine
+∞
11.5
11
*
JFG70
NOMESCO Finland
Conversion of continent ileostomy to conventional ileostomy
+∞
11.5
11
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
11.4
776
5997
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.7
11.4
28
42
M04AA01
ATC
allopurinol; systemic
1.5
11.3
421
2917
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
11.3
382
2592
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
11.3
117
547
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.2
11.3
115
536
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.4
11.2
93
393
JAH01
NOMESCO Finland
Laparoscopy
1.8
11.2
186
1044
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
11.1
822
6433
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
11.0
944
7545
Z93.3
ICD-10 Finland
Colostomy status
3.8
11.0
45
119
K86.1
ICD-10 Finland
Other chronic pancreatitis
3.7
11.0
46
124
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.5
11.0
84
339
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
11.0
1117
9135
M01AB55
ATC
diclofenac, combinations; oral
1.7
10.9
231
1398
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
10.9
275
1743
M01AH02
ATC
rofecoxib; oral
1.4
10.8
461
3287
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.1
10.8
117
559
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.7
10.8
45
121
M02AA07
ATC
piroxicam; topical
1.2
10.8
1430
12069
SPAT1312
SPAT
General health counselling
1.2
10.7
1440
12167
5604
FHL
Vascular preparation or cannulation in the operating room
7.2
10.7
25
35
C01DA14
ATC
isosorbide mononitrate; oral
1.5
10.7
414
2896
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
10.7
411
2874
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
6.7
10.6
26
39
-
ICD-10 Finland
NA
2.2
10.6
101
457
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.2
10.6
100
449
L04AB02
ATC
infliximab; parenteral
60.1
10.6
12
*
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
10.6
266
1687
D07AA02
ATC
hydrocortisone; topical
1.4
10.5
599
4498
5781B
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]
14.2
10.5
17
12
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
10.4
243
1508
K83
ICD-10 Finland
Other diseases of biliary tract
110.2
10.4
11
*
6437
FHL
Rectum resection and sphincter-sparing through-anastomosis
+∞
10.4
10
*
56398
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Alia definita
+∞
10.4
10
*
M02AA10
ATC
ketoprofen; topical
1.4
10.4
596
4479
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.9
10.4
61
212
Y0599
ICD-8 Finland
Investigation of digestive system
2.6
10.3
70
267
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
8.8
10.2
21
24
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
10.2
199
1173
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.4
10.2
83
348
UJF32
SPAT
NA
2.6
10.2
72
278
D95
ICPC
Anal fissure/perianal abscess
3.4
10.2
47
138
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
10.2
323
2167
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
5.0
10.1
31
62
WX004
NOMESCO Finland
Patient-controlled sedation
5.0
10.1
31
62
M05BA07
ATC
risedronic acid; oral
2.2
10.1
97
441
WX704
NOMESCO Finland
Intubation
1.6
10.1
286
1868
K85.8
ICD-10 Finland
Other acute pancreatitis
4.2
10.1
37
89
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
10.1
507
3725
L52
ICD-10 Finland
Erythema nodosum
3.8
10.0
41
109
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
2.9
10.0
58
199
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
10.0
418
2966
RS224
NOMESCO Finland
NA
4.5
10.0
34
76
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
10.0
190
1114
A02BC04
ATC
rabeprazole; oral
1.5
10.0
331
2241
D06
ICPC
Abdominal pain localized other
1.5
10.0
319
2142
JFG96
NOMESCO Finland
Other operation on intestinal stoma or pouch
40.1
10.0
12
*
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
10.0
520
3849
N06AX16
ATC
venlafaxine; oral
1.4
9.9
585
4419
WZA90
NOMESCO Finland
Other doctors statement
1.3
9.9
1022
8357
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
9.9
203
1218
Z01.2
ICD-10 Finland
Dental examination
1.2
9.9
1919
16830
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
9.9
762
5996
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
3.8
9.8
40
106
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
9.8
499
3679
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
9.8
225
1394
1470
FHL
Rectoscopy
3.8
9.7
40
107
G44.2
ICD-10 Finland
Tension-type headache
1.4
9.7
535
3993
A12BA01
ATC
potassium chloride; oral
2.0
9.7
124
634
N05BA01
ATC
diazepam; systemic, rectal
1.4
9.7
512
3794
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
9.7
3245
29938
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
6.1
9.6
25
41
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
9.6
316
2139
R03BA05
ATC
fluticasone; inhalant
1.3
9.6
756
5964
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
9.6
275
1802
L28
ICPC
Limited function/disability (L)
1.4
9.6
497
3674
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.6
9.6
69
272
R4110
NOMESCO Finland
Physiotherapy
1.3
9.5
1069
8830
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
9.5
570
4319
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
9.5
473
3472
E000002
ATC
NA
1.4
9.5
489
3613
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
9.5
246
1574
J01EA01
ATC
trimethoprim; systemic
1.3
9.5
933
7584
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.7
9.4
205
1251
K52.1
ICD-10 Finland
Toxic gastroenteritis and colitis
100.2
9.4
10
*
N06AB03
ATC
fluoxetine; oral
1.4
9.4
496
3677
Z90.4
ICD-10 Finland
Acquired absence of other parts of digestive tract
30.0
9.4
12
*
N82.2
ICD-10 Finland
Fistula of vagina to small intestine
+∞
9.4
9
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
9.4
9
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.2
9.3
92
425
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
9.3
280
1854
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
3.0
9.3
50
165
R06AX27
ATC
desloratadine; oral
1.2
9.3
1236
10407
5781A
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[MELAENA]
8.0
9.3
20
25
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
9.3
155
874
J01MA06
ATC
norfloxacin; oral
1.4
9.3
492
3648
J01FA15
ATC
telithromycin; oral
1.4
9.3
414
2976
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
9.3
2599
23552
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
9.3
1769
15467
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
9.5
9.2
18
19
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
9.2
193
1163
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.4
9.2
439
3195
K62.6
ICD-10 Finland
Ulcer of anus and rectum
3.4
9.2
43
128
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
9.2
472
3479
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
9.2
1439
12332
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
6.0
9.2
24
40
JJA20
NOMESCO Finland
Open biopsy of liver
6.0
9.2
24
40
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
9.2
426
3090
R03DC03
ATC
montelukast; oral
1.3
9.1
652
5072
N05CD07
ATC
temazepam; oral
1.4
9.1
387
2757
A02BA03
ATC
famotidine; systemic
1.9
9.1
126
667
R03BB04
ATC
tiotropium bromide; inhalant
1.5
9.1
316
2163
XQ800
NOMESCO Finland
Prick test
1.5
9.0
328
2267
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
5.6
9.0
25
45
1CB02
NOMESCO Finland
NA
36.7
9.0
11
*
L17
ICPC
Foot/toe symptom/complaint
1.3
9.0
976
8023
L30.3
ICD-10 Finland
Infective dermatitis
1.9
9.0
133
721
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
9.0
1523
13155
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.9
8.9
52
180
E000003
ATC
NA
1.7
8.9
190
1153
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.1
8.9
91
428
JFA70
NOMESCO Finland
Suture of small intestine
5.5
8.9
25
46
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
12.5
8.8
15
12
SPAT1229
SPAT
Assessment of need for aid
1.6
8.8
241
1563
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
8.8
751
5985
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
8.8
629
4892
C07AA05
ATC
propranolol; systemic
1.3
8.8
799
6422
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
8.8
356
2513
JFB20
NOMESCO Finland
Ileocaecal resection
4.9
8.8
27
55
K63.3
ICD-10 Finland
Ulcer of intestine
10.7
8.8
16
15
D02AE01
ATC
carbamide; topical
1.5
8.8
272
1816
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.7
8.8
180
1082
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.8
8.8
135
743
D07AB08
ATC
desonide; topical
1.4
8.7
436
3200
TGC00
NOMESCO Finland
Bronchial lavation
2.1
8.7
97
474
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.9
8.7
128
692
4AA17
NOMESCO Finland
NA
50.0
8.7
10
*
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
2.2
8.6
81
365
U05
ICPC
Urination problems other
1.8
8.6
149
852
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
8.6
674
5307
WX320
NOMESCO Finland
Spinalanesthesy
1.3
8.6
842
6833
N30.0
ICD-10 Finland
Acute cystitis
1.4
8.6
480
3592
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
8.6
784
6309
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.5
8.5
271
1819
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
8.5
150
862
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.5
8.5
63
253
ZX100
NOMESCO Finland
Oral
2.5
8.5
62
245
R03BA01
ATC
beclometasone; inhalant
1.3
8.5
536
4089
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
2.9
8.5
50
175
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
8.5
1298
11082
N06AB04
ATC
citalopram; systemic
1.3
8.5
848
6899
KH1AD
NOMESCO Finland
CT of urinary organs
1.8
8.5
127
694
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
8.5
199
1245
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.4
1368
11745
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.1
8.4
92
444
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
5.3
8.4
24
45
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
8.4
553
4245
6522
FHL
Ileostomy
90.2
8.4
9
*
A99
ICPC
Disease/condition unspecnature/site
1.5
8.4
284
1934
R31
ICD-10 Finland
Unspecified haematuria
1.5
8.4
311
2161
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
12.8
8.4
14
11
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
8.4
204
1286
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
6.7
8.3
20
30
M075, K509
ICD-10 Finland
NA
+∞
8.3
8
*
M075, K515
ICD-10 Finland
NA
+∞
8.3
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
8.3
292
2006
R05
ICD-10 Finland
Cough
1.3
8.3
737
5906
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
8.3
1182
10010
L43.8
ICD-10 Finland
Other lichen planus
2.4
8.3
68
289
UDC00
NOMESCO Finland
Ear microscopy
1.5
8.3
274
1859
JFB30
NOMESCO Finland
Right hemicolectomy
2.8
8.3
49
173
JFC00
NOMESCO Finland
Entero-enterostomy
9.4
8.3
16
17
RS220
NOMESCO Finland
NA
2.4
8.2
64
264
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
3.2
8.2
40
124
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.6
8.2
58
228
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.0
8.2
102
520
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
8.2
423
3125
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
8.2
316
2212
WW200
SPAT
NA
0.7
8.2
231
3331
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
8.2
199
1253
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.9
8.2
25
51
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
8.1
257
1723
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.3
8.1
73
325
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.8
8.1
50
182
H15.1
ICD-10 Finland
Episcleritis
2.4
8.1
63
260
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
33.4
8.1
10
*
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
8.1
8.1
17
21
I95.9
ICD-10 Finland
Hypotension, unspecified
2.9
8.1
47
164
D84.18
ICD-10 Finland
Other specified defect in the complement system
17.2
8.1
12
7
WX720
NOMESCO Finland
Own respiration
1.7
8.0
149
871
K55.2
ICD-10 Finland
Angiodysplasia of colon
4.8
8.0
25
52
RS221
NOMESCO Finland
NA
2.4
8.0
66
281
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.0
8.0
92
456
B82
ICPC
Anaemia other/unspecified
2.2
8.0
79
364
Z71.8
ICD-10 Finland
Other specified counselling
1.2
8.0
1017
8504
D17
ICPC
Incontinence of bowel
3.9
8.0
31
80
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
8.0
145
843
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
8.0
627
4939
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
2.4
8.0
65
274
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.2
8.0
77
355
K56.2
ICD-10 Finland
Volvulus
4.1
7.9
29
71
S29
ICPC
Skin symptom/complaint other
1.3
7.9
619
4874
R60.0
ICD-10 Finland
Localized oedema
1.4
7.9
357
2575
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
7.9
297
2070
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.3
7.9
68
296
AN1
HP
Coronary angiography
1.4
7.9
340
2431
WX610
NOMESCO Finland
Patient controlled analgesia
3.3
7.9
37
112
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.5
7.9
263
1785
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
2.9
7.9
46
161
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.1
7.9
88
430
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
4.9
7.9
24
49
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.5
7.8
59
241
5770A
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]
6.1
7.8
20
33
K59.8
ICD-10 Finland
Other specified functional intestinal disorders
4.6
7.8
25
54
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
7.8
83
399
K29.1
ICD-10 Finland
Other acute gastritis
2.5
7.8
58
235
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
7.7
634
5024
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.4
7.7
62
262
A04.5
ICD-10 Finland
Campylobacter enteritis
3.0
7.7
41
136
M81.8
ICD-10 Finland
Other osteoporosis
3.6
7.7
32
88
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
7.7
469
3561
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
7.7
139
808
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
7.7
255
1729
A07EB01
ATC
cromoglicic acid; oral
15.0
7.7
12
8
A98
ICPC
Health maint/preventive medicine
1.3
7.7
5263
51373
N20.1
ICD-10 Finland
Calculus of ureter
1.7
7.7
137
793
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
7.7
122
680
A29
ICPC
General symptom/complaint other
1.4
7.7
383
2812
R13
ICD-10 Finland
Dysphagia
1.6
7.7
214
1395
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.4
7.7
63
267
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
5.9
7.7
20
34
D82
ICPC
Teeth/gum disease
1.2
7.7
1587
13931
N03AE01
ATC
clonazepam; systemic
1.6
7.6
206
1333
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.0
7.6
42
143
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
7.6
257
1753
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.0
7.6
91
459
A03FA02
ATC
cisapride; oral, rectal
1.5
7.6
258
1762
K07.60
ICD-10 Finland
Snapping jaw
1.6
7.6
202
1303
N82.4
ICD-10 Finland
Other female intestinal-genital tract fistulae
25.0
7.6
10
*
R05
ICPC
Cough
1.2
7.6
880
7285
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.1
7.6
39
127
B80
ICPC
Iron deficiency anaemia
2.1
7.5
83
403
A04.6
ICD-10 Finland
Enteritis due to Yersinia enterocolitica
8.8
7.5
15
17
R96
ICPC
Asthma
1.4
7.5
303
2140
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
7.5
385
5048
I84.3
ICD-10 Finland
External thrombosed hemorrhoids
2.7
7.5
48
177
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
7.5
131
752
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.6
7.5
187
1191
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
7.5
108
582
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.2
7.4
70
317
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
7.4
231
1544
R07.3
ICD-10 Finland
Other chest pain
1.4
7.4
324
2323
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.7
7.4
150
900
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.3
7.4
67
297
A41.8
ICD-10 Finland
Other specified sepsis
2.5
7.4
55
222
J01DA06
ATC
[U] cefuroxime; systemic
1.3
7.4
593
4688
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
7.4
89
450
Z3229
NOMESCO Finland
Other healthcare associate professional
1.4
7.4
297
2101
K63.2
ICD-10 Finland
Fistula of intestine
7.6
7.4
16
21
KBV10
NOMESCO Finland
Removal of stent from ureter
3.1
7.4
38
124
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
7.4
206
1346
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
7.4
233
1565
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.4
1072
9093
SPAT1131
SPAT
Colonoscopy
1.8
7.3
111
608
JKA20
NOMESCO Finland
Cholecystectomy
2.0
7.3
84
417
M073, K519
ICD-10 Finland
NA
+∞
7.3
7
*
JFG53
NOMESCO Finland
Revision of ileal pelvic pouch
+∞
7.3
7
*
JGB60
NOMESCO Finland
Excision of rectum and ileoanal anastomosis
+∞
7.3
7
*
K52.8
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
+∞
7.3
7
*
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
7.3
7
*
JFH31
NOMESCO Finland
Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
7.3
7
*
K60.1
ICD-10 Finland
Chronic anal fissure
2.0
7.3
90
458
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.2
7.3
69
315
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
4.1
7.3
26
63
K92.0
ICD-10 Finland
Haematemesis
2.0
7.3
84
419
L73.2
ICD-10 Finland
Hidradenitis suppurativa
2.6
7.3
48
183
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
7.3
147
885
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.5
7.3
32
93
N17.8
ICD-10 Finland
Other acute renal failure
3.1
7.2
37
120
A01
ICPC
Pain general/multiple sites
1.5
7.2
257
1773
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.1
7.2
81
397
P01BA02
ATC
hydroxychloroquine; oral
1.4
7.2
302
2151
K92.9
ICD-10 Finland
Disease of digestive system, unspecified
3.7
7.2
29
78
R33
ICD-10 Finland
Retention of urine
1.5
7.2
227
1524
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
2.2
7.2
66
298
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
7.3
7.2
16
22
D05AX52
ATC
calcipotriol, combinations; topical
1.5
7.2
207
1364
JN4CD
NOMESCO Finland
Very extensive body CT
1.8
7.1
119
676
A10AE04
ATC
insulin glargine; parenteral
1.4
7.1
340
2479
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.7
7.1
133
780
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
2.4
7.1
54
223
SPAT1216
SPAT
Assessment of functional ability
1.3
7.1
470
3619
SFA00
NOMESCO Finland
Small filling
1.3
7.1
509
3962
K86.8
ICD-10 Finland
Other specified diseases of pancreas
5.3
7.1
20
38
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
7.1
998
8436
G47.3
ICD-10 Finland
Sleep apnoea
1.2
7.0
827
6851
5BA08
NOMESCO Finland
NA
3.9
7.0
27
70
JHD96
NOMESCO Finland
Other incision of anal sphincter
8.8
7.0
14
16
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
7.0
351
2583
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
10.0
7.0
13
13
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
10.0
7.0
13
13
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.9
7.0
90
465
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
3.3
7.0
32
96
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.7
7.0
45
167
L01BB01
ATC
NA
7.0
7.0
16
23
L29.9
ICD-10 Finland
Pruritus, unspecified
2.0
7.0
84
427
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
1.9
6.9
88
456
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.8
6.9
104
573
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
7.5
6.9
15
20
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
6.9
113
639
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.7
6.9
126
739
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
6.9
276
1953
M01AX01
ATC
nabumetone; oral
1.6
6.8
148
908
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
3.5
6.8
29
82
J04BA02
ATC
dapsone; oral
3.9
6.8
26
67
SPAT1097
SPAT
Recording of ECG
1.3
6.8
494
3849
D05AX02
ATC
calcipotriol; topical
1.7
6.8
146
891
R06AX22
ATC
ebastine; oral
1.3
6.8
706
5763
JEA01
NOMESCO Finland
Laparoscopic appendectomy
1.6
6.8
156
971
R2110
NOMESCO Finland
Giving the first information
1.4
6.8
267
1877
E87.5
ICD-10 Finland
Hyperkalaemia
2.4
6.8
53
222
N06AX26
ATC
vortioxetine; oral
1.5
6.8
231
1576
K45.0
ICD-10 Finland
Other specified abdominal hernia with obstruction, without gangrene
8.2
6.8
14
17
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.5
6.8
209
1399
K20
ICD-10 Finland
Oesophagitis
2.2
6.8
63
285
K31.9
ICD-10 Finland
Disease of stomach and duodenum, unspecified
10.9
6.8
12
11
ZX108
NOMESCO Finland
Inhalation
3.2
6.8
33
104
D05AX03
ATC
calcitriol; topical
2.3
6.8
58
254
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
6.8
262
1838
L20.0
ICD-10 Finland
Besnier prurigo
1.4
6.8
290
2075
M07.6
ICD-10 Finland
Other enteropathic arthropathies
40.1
6.8
8
*
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
5.3
6.7
19
36
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
16.7
6.7
10
6
K83.3
ICD-10 Finland
Fistula of bile duct
16.7
6.7
10
6
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
16.7
6.7
10
6
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
16.7
6.7
10
6
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
6.7
621
5000
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.5
6.7
227
1550
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.6
6.7
166
1055
XW000
NOMESCO Finland
Bone marrow biopsy
1.7
6.7
131
781
107
Kela drug reimbursment
Pernicious anaemia
2.2
6.7
60
269
N20.0
ICD-10 Finland
Calculus of kidney
2.0
6.7
81
410
KCV04
NOMESCO Finland
Distension of bladder with fluid
2.8
6.7
39
138
W19
ICD-10 Finland
Unspecified fall
1.4
6.6
340
2511
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
6.6
492
3848
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
4.9
6.6
20
41
K66.0
ICD-10 Finland
Peritoneal adhesions
3.7
6.6
27
74
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.1
6.6
67
315
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
4.4
6.6
22
50
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.6
2436
22343
A04AA01
ATC
ondansetron; systemic, rectal
1.5
6.6
220
1498
L12
ICPC
Hand/finger symptom/complaint
1.3
6.6
536
4242
NG1DA
NOMESCO Finland
X-ray of knees
2.2
6.6
62
284
R42
ICD-10 Finland
Dizziness and giddiness
1.2
6.6
734
6043
K29.6
ICD-10 Finland
Other gastritis
2.6
6.6
44
170
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.6
6.6
166
1059
A04
ICPC
Weakness/tiredness general
1.3
6.5
460
3569
R06AE09
ATC
levocetirizine; oral
1.3
6.5
609
4909
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.5
6.5
47
189
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
6.5
981
8339
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
6.5
303
2202
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
6.5
1107
9525
5609X
ICD-9 Finland
Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction
6.8
6.5
15
22
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
6.8
6.5
15
22
A10BH01
ATC
sitagliptin; oral
1.4
6.5
288
2077
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.8
6.5
102
568
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
6.5
278
1992
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.3
6.5
56
247
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
6.5
1265
11024
K11.2
ICD-10 Finland
Sialoadenitis
1.7
6.5
113
653
WX419
NOMESCO Finland
Other general anesthesy
2.4
6.4
49
201
LEE20
NOMESCO Finland
Closure of urovaginal fistula using graft or flap
69.9
6.4
7
*
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
6.4
175
1141
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.9
6.4
81
419
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.9
6.4
83
434
JG1CG
NOMESCO Finland
Extensive MRI of rectum
3.7
6.3
25
67
ZX140
NOMESCO Finland
Intra articular
2.7
6.3
39
144
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.3
6.3
29
88
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
6.5
6.3
15
23
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.8
6.3
95
524
ZX198
NOMESCO Finland
Other local administration
2.8
6.3
37
132
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
4.2
6.3
22
53
K75.4
ICD-10 Finland
Autoimmune hepatitis
5.9
6.3
16
27
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
6.3
282
2035
6561
FHL
Removal of fasteners and related measures
5.5
6.3
17
31
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
6.3
623
5060
K85.3
ICD-10 Finland
Drug-induced acute pancreatitis
18.0
6.3
9
5
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
+∞
6.2
6
*
JFH40
NOMESCO Finland
Proctocolectomy and continent ileostomy
+∞
6.2
6
*
4AB06
NOMESCO Finland
NA
+∞
6.2
6
*
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.4
6.2
49
207
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.3
6.2
54
238
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
6.2
145
910
TQW80
NOMESCO Finland
Local dermatologic skincare
1.8
6.2
92
504
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
4.8
6.2
19
40
N05BB01
ATC
hydroxyzine; systemic
1.5
6.2
232
1618
A87.9
ICD-10 Finland
Viral meningitis, unspecified
2.8
6.2
37
134
M01AE01
ATC
ibuprofen; systemic, rectal
0.8
6.2
4381
45389
J01AA07
ATC
tetracycline; systemic
1.3
6.2
657
5377
L03
ICPC
Low back symptom/complaint
1.2
6.2
947
8063
H53.1
ICD-10 Finland
Subjective visual disturbances
1.5
6.2
216
1486
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
6.2
1356
11931
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
6.2
780
6509
Z50.1
ICD-10 Finland
Other physical therapy
1.5
6.1
183
1215
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
6.1
223
1549
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
3.3
6.1
28
85
N05AH04
ATC
quetiapine; oral
1.2
6.1
677
5565
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.6
6.1
137
852
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.3
6.1
50
215
K60.0
ICD-10 Finland
Acute anal fissure
2.5
6.1
44
178
D06BB10
ATC
imiquimod; topical
1.6
6.1
164
1068
WX702
NOMESCO Finland
Supraglottic ventilation device
1.5
6.1
200
1360
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
6.1
1106
9571
B01AB04
ATC
dalteparin; parenteral
1.6
6.1
156
1004
WX882
NOMESCO Finland
High dependency care
1.8
6.0
98
553
120
Kela drug reimbursment
Hypogammaglobulinaemia
4.9
6.0
18
37
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.5
6.0
192
1295
-60
ICPC
Result test/procedure
1.5
6.0
192
1296
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
2.2
6.0
53
237
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.7
6.0
109
638

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3075
16562
2.68
312.44
5.3
3.2
u/l
30.4
34.6
2.78
2829
15786
(40760892) CBC W Ordered Manual Differential panel - Blood
2397
11407
2.78
311.68
9.9
4.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
697
1328
5.78
307.65
1.7
1.2
titre
1046.7
1060.5
—
6
37
(3013115) Eosinophils [#/volume] in Blood
4947
25507
5.43
307.65
14.2
5.9
e9/l
0.2
0.2
1.59
4632
22470
(3001604) Monocytes [#/volume] in Blood
4853
24522
5.31
307.65
14.0
5.6
e9/l
0.6
0.6
0.28
4523
21234
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
2067
2634
11.21
307.65
2.3
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
5082
28323
5.16
307.65
16.1
8.9
e9/l
4.0
4.1
1.65
4757
24686
(3002030) Lymphocytes/100 leukocytes in Blood
4623
24008
4.51
307.65
14.3
5.8
%
28.5
28.7
0.86
4456
22451
(3025941) Bacteria identified in Stool by Culture
1065
2739
4.48
307.65
1.5
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
5389
36214
4.44
307.65
8.1
3.7
mm/h
12.2
10.7
14.35
5148
33757
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
565
63
98.45
307.65
3.0
2.1
au/ml
93.2
175.8
0.63
84
11
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
567
926
6.63
307.65
5.0
3.4
%
57.0
57.1
0.08
567
926
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4244
19206
4.73
307.65
3.8
2.2
nmol/l
74.9
75.3
0.35
4089
17505
(3021440) Promyelocytes/100 leukocytes in Blood
1268
3616
4.14
307.65
6.2
4.2
%
0.0
0.2
1.99
383
950
(3017181) Myelocytes/100 leukocytes in Blood
1335
3783
4.21
307.65
6.0
4.2
%
0.7
0.9
2.68
413
1024
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
235
81
30.10
307.65
2.1
1.3
au/ml
84.0
195.7
—
40
7
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5758
36776
7.81
307.65
18.3
6.8
u/l
76.4
77.0
0.44
5657
34724
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1187
1397
10.24
307.65
1.8
1.5
iu/ml
0.6
5.3
0.59
259
295
(3006315) Basophils [#/volume] in Blood
4873
24607
5.38
307.65
14.0
5.7
e9/l
0.0
0.0
3.90
4550
21290
(3019198) Lymphocytes [#/volume] in Blood
4901
25391
5.24
307.65
14.0
5.7
e9/l
1.9
2.0
4.87
4605
22451
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4009
24168
2.82
307.65
8.7
6.0
umol/l
10.4
11.2
4.77
3855
22881
(3006504) Eosinophils/100 leukocytes in Blood
4576
23019
4.64
307.65
14.1
5.8
%
2.8
2.9
1.22
4410
21497
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
301
102
30.95
307.65
2.6
1.3
mg/l
9.2
9.2
0.01
253
80
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
695
942
8.17
307.65
4.1
6.7
iu/ml
1236.5
691.9
0.83
88
137
(3022096) Basophils/100 leukocytes in Blood
4521
22293
4.67
307.65
14.2
5.9
%
0.7
0.7
14.41
4350
20850
(42870588) Differential panel, method unspecified - Blood
3865
16234
4.59
307.65
12.6
5.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1198
3422
4.09
307.65
6.3
4.2
%
0.0
0.3
1.03
324
792
(3018010) Neutrophils/100 leukocytes in Blood
4590
23635
4.50
307.65
13.5
5.7
%
57.1
56.7
2.23
4427
22189
(3002179) Metamyelocytes/100 leukocytes in Blood
1259
3462
4.30
307.65
5.6
3.9
%
0.4
0.6
4.27
309
738
(3022145) Colonoscopy Study observation
3552
4298
17.72
307.65
2.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
698
1341
5.73
307.65
1.8
1.2
titre
76.7
133.1
0.67
63
116
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2935
11233
4.03
307.65
4.1
2.1
mg/l
2.9
2.9
0.50
2676
9624
(3019069) Monocytes/100 leukocytes in Blood
4586
23166
4.63
307.65
14.5
6.1
%
8.7
8.5
7.14
4427
21772
(3024561) Albumin [Mass/volume] in Serum or Plasma
4859
19010
7.88
307.65
10.2
4.6
g/l
36.5
36.0
8.40
4700
17659
(3048689) Calprotectin [Mass/mass] in Stool
4483
5327
26.92
307.65
7.5
1.3
ug/g
242.3
91.9
74.89
4248
4054
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
636
60
117.83
307.65
3.7
2.3
mg/l
8.0
5.8
3.09
540
41
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2777
14583
2.62
291.95
4.4
2.5
u/l
59.9
57.5
1.31
2636
13497
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
512
868
6.33
291.20
1.7
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
355
410
9.12
283.67
2.0
1.2
titre
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
971
2862
3.83
282.48
2.0
1.8
g/l
1.3
1.3
0.74
908
2635
(3017143) Hepatitis C virus Ab [Presence] in Serum
1654
6830
2.93
276.44
1.5
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1511
5970
3.02
273.26
2.9
2.5
%
21.8
23.6
4.54
1309
5175
(3005719) IgG [Mass/volume] in Serum or Plasma
1114
3714
3.43
267.91
2.9
2.6
g/l
11.5
10.4
13.81
1040
3400
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
551
1088
5.46
266.35
1.5
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3613
22264
2.47
259.41
4.1
2.8
ug/l
103.6
116.2
1.99
3441
20859
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1555
6463
2.87
254.32
2.9
2.4
g/l
2.4
2.4
2.18
1489
6015
(3022948) Iron [Moles/volume] in Serum or Plasma
1642
7038
2.80
253.18
3.0
2.4
umol/l
12.7
13.7
6.16
1577
6563
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1173
4177
3.22
252.25
4.2
2.3
g/l
0.2
0.2
3.43
1111
3898
(3021589) Normoblasts [#/volume] in Blood
3558
22093
2.41
246.36
18.1
8.7
e9/l
0.0
0.0
2.23
3178
17982
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
302
370
8.52
229.81
1.5
1.2
titre
341.7
191.8
0.43
18
11
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
302
370
8.52
229.81
1.5
1.2
titre
286.3
152.5
1.96
121
60
(3024980) IgG subclass 4 [Mass/volume] in Serum
425
783
5.75
220.82
2.3
1.6
g/l
0.8
0.8
0.09
354
595
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1904
9359
2.48
217.24
1.6
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1557
6962
2.64
216.76
1.7
1.3
titre
538.8
532.7
0.04
438
1338
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
326
491
6.95
206.99
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
323
482
7.01
206.86
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
320
483
6.93
202.74
1.8
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
504
1186
4.53
196.65
1.9
1.4
iu/ml
6.6
16.0
1.11
16
25
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
312
478
6.82
194.85
1.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
311
475
6.84
194.79
1.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
311
479
6.78
193.24
1.8
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
583
1557
4.03
192.27
2.0
1.6
titre
390.4
350.0
0.12
47
54
(3009445) Proteinase 3 Ab [Units/volume] in Serum
654
1919
3.69
188.31
1.8
1.6
u/ml
4.6
16.6
2.02
77
44
(3023368) Bacteria identified in Blood by Culture
2151
11790
2.25
185.72
5.1
4.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3086
19565
2.14
183.35
2.5
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
589
1640
3.86
182.92
1.9
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2851
17640
2.13
179.39
9.6
8.0
inr
1.1
1.2
8.10
972
5239
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
118
45
26.71
171.90
1.0
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3358
22380
2.08
170.06
7.9
6.6
mmol/l
1.2
1.2
0.46
2823
18978
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5989
51294
4.62
165.35
28.5
12.1
mg/l
17.8
22.9
40.44
5409
39696
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3072
20256
2.01
155.25
6.9
6.0
mmol/l
1.2
1.2
0.72
2842
18445
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
433
1103
4.14
151.57
1.3
1.3
u/ml
286.1
252.1
1.21
250
703
(40758558) Short blood count panel - Blood
2126
12396
2.08
150.09
11.2
7.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
446
1172
4.02
149.59
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
244
381
6.62
149.36
2.3
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
4399
33714
2.02
135.56
5.2
3.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
460
1345
3.61
131.93
1.4
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1797
10251
2.05
131.38
1.8
1.4
g/l
2.5
2.3
2.45
1302
6408
(42529406) Shigella sp [Presence] in Stool by Culture
460
1354
3.59
130.58
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
455
1330
3.61
130.52
1.4
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1438
7591
2.16
128.79
2.1
1.7
nmol/l
1166.7
1165.7
0.01
996
5829
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
149
159
9.57
125.90
1.9
1.9
u/ml
3788.7
20335.2
0.42
21
24
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
289
630
4.76
123.19
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1237
6317
2.19
119.50
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
975
4517
2.37
118.84
3.6
2.4
u/l
42.7
48.3
0.21
876
3876
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1114
5488
2.25
117.41
4.6
2.8
umol/l
6.9
7.8
0.90
987
4761
(3048929) Epstein Barr virus Ab [Presence] in Serum
552
1938
3.03
117.18
1.3
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
451
1406
3.38
116.83
5.4
3.4
u/ml
54.5
3899.9
1.22
406
1195
(3014148) Varicella zoster virus Ab [Titer] in Serum
311
750
4.31
116.69
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2663
17920
1.84
115.32
2.2
1.9
pmol/l
95.3
96.5
0.62
1633
9442
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
318
799
4.14
112.96
1.1
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
2089
13173
1.88
110.05
4.4
4.0
ph
7.4
7.4
0.34
432
2550
(40768441) Liver Pathology biopsy report
192
322
6.12
109.39
1.9
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1898
11754
1.88
104.79
1.8
1.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1958
12255
1.87
104.49
6.4
3.9
%
93.9
91.8
3.32
1914
11950
(3010375) cycloSPORINE [Mass/volume] in Blood
157
230
6.98
101.92
18.7
27.0
ug/l
135.5
122.9
1.03
140
184
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
210
414
5.21
100.60
1.2
1.1
u/l
58.3
63.3
0.35
136
276
(3013826) Glucose [Moles/volume] in Serum or Plasma
3668
27881
1.76
99.39
6.2
4.6
mmol/l
6.6
6.6
0.25
3478
25858
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
85
56
15.37
97.37
2.4
1.6
mg/l
2.1
1.5
1.20
72
46
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1564
9302
1.91
96.52
2.4
1.6
pmol/l
26709835.3
29988978.4
0.09
1404
7863
(3004809) Band form neutrophils/100 leukocytes in Blood
272
685
4.11
96.19
3.1
3.4
%
1.0
1.4
1.31
193
538
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
264
663
4.11
93.70
1.1
1.1
g/l
1.5
1.5
0.72
243
594
(3036481) Cortisol [Moles/volume] in Serum or Plasma
925
4603
2.18
93.40
2.4
2.2
nmol/l
324.1
373.0
12.48
864
4231
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
505
1917
2.78
92.29
1.3
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
57
16
35.94
90.99
1.1
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5463
47538
2.15
89.80
21.9
11.1
ml/min/173m2
88.1
86.4
7.10
4811
38993
(3042936) Bacteria identified in Isolate by Culture
1172
6588
1.96
84.24
2.3
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
830
4141
2.16
82.59
4.6
3.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
825
4117
2.16
82.01
4.8
4.0
ug/l
7.3
33.0
2.11
653
3268
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
159
297
5.47
80.84
1.3
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5990
54723
3.05
80.35
23.3
9.2
u/l
27.4
27.5
0.29
5935
52960
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
159
300
5.41
79.96
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
714
3415
2.23
78.76
2.9
2.7
e9/l
4.3
4.1
0.73
502
2771
(3009261) Glucose [Presence] in Urine by Test strip
3187
24261
1.64
77.26
4.4
3.3
estimate
0.0
0.0
0.67
889
4344
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1062
5935
1.95
76.99
6.8
6.4
mmol/l
1.0
1.0
2.04
1018
5553
(3031040) Bacteria [#/volume] in Urine by Automated count
3941
31666
1.66
76.74
5.1
4.0
e6/l
2748.1
1288.5
0.42
41
404
(3017354) Segmented neutrophils/100 leukocytes in Blood
180
400
4.60
74.79
3.0
3.5
%
58.7
56.6
0.54
103
256
(3035350) Ketones [Presence] in Urine by Test strip
3144
23975
1.62
74.71
4.4
3.3
estimate
0.0
0.0
1.28
879
4361
(3019550) Sodium [Moles/volume] in Serum or Plasma
5706
51254
2.24
74.47
22.8
13.7
mmol/l
139.4
139.7
19.56
5600
49913
(3023103) Potassium [Moles/volume] in Serum or Plasma
5717
51442
2.24
73.45
22.9
13.9
mmol/l
3.9
4.0
22.83
5600
49989
(3021601) Nitrite [Presence] in Urine by Test strip
3139
24021
1.61
72.80
5.6
4.5
estimate
0.0
0.0
0.80
903
4505
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
135
240
5.73
72.38
1.2
1.1
u/l
77.7
82.4
0.24
111
201
(3021960) Folate [Moles/volume] in Serum or Plasma
1539
9820
1.75
72.20
1.7
1.5
nmol/l
20.3
20.3
0.02
1364
8517
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
133
240
5.64
70.19
1.7
1.5
u/l
4.7
5.8
0.33
69
114
(3029937) Albumin [Presence] in Urine by Test strip
1871
12688
1.68
69.76
5.1
3.6
estimate
0.0
0.0
0.02
876
4321
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1188
7086
1.83
69.72
2.1
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
876
4734
1.99
69.45
3.9
2.7
%
1.8
1.8
1.68
788
4221
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
130
232
5.70
69.42
1.2
1.1
u/l
19.3
20.1
0.08
108
192
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
127
225
5.74
68.34
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
127
231
5.59
66.46
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
107
167
6.50
65.43
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
107
167
6.50
65.43
1.5
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
330
1208
2.83
64.20
1.6
1.4
ug/g
279.6
287.8
0.30
206
683
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
155
346
4.57
64.04
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
161
371
4.43
63.92
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1493
9726
1.70
63.78
3.0
2.5
e6/l
6.2
5.8
0.42
1357
8508
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
155
348
4.54
63.58
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
99
148
6.78
63.06
1.2
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1722
11690
1.65
62.64
1.3
1.3
u/ml
1.3
1.9
1.26
428
3220
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
258
837
3.17
62.15
5.1
3.4
u/ml
97.2
634.4
1.06
235
773
(3021879) Hepatitis B virus core Ab [Presence] in Serum
830
4565
1.94
62.05
1.4
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
250
799
3.22
61.75
3.2
3.3
u/ml
581.6
768.5
0.21
20
49
(3004716) Salmonella sp identified in Stool by Organism specific culture
575
2783
2.17
60.93
1.5
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
262
871
3.10
60.55
1.2
1.3
titre
162.9
236.0
—
7
20
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2953
22898
1.55
60.26
5.1
3.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
662
3424
2.04
58.81
2.9
2.7
e9/l
75.0
70.5
1.93
520
2541
(3044640) Blood type and Crossmatch panel - Blood
2106
15195
1.58
58.80
3.1
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
315
1178
2.76
58.80
1.3
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1986
14166
1.59
58.09
3.7
3.1
e6/l
81.3
100.4
0.28
1644
10755
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2491
18727
1.55
57.68
4.6
3.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
742
4022
1.96
57.65
10.2
8.2
mmol/l
9.0
9.1
0.11
709
3861
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1174
7393
1.72
55.84
5.1
3.7
mmol/l
0.8
0.8
5.50
1104
6935
(3014576) Chloride [Moles/volume] in Serum or Plasma
935
5526
1.81
55.36
9.3
7.4
mmol/l
104.6
104.5
0.31
919
5406
(3052851) Hemolysis interference index of Serum or Plasma
340
1363
2.58
55.25
3.4
3.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
289
1076
2.77
54.37
1.3
1.5
u/ml
105.5
112.5
0.52
57
209
(3018095) Leukocytes [#/volume] in Urine
2257
16824
1.53
53.10
4.2
3.5
e6/l
83.9
84.0
0.00
1740
11661
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
323
1294
2.58
52.53
1.2
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1806
12945
1.55
50.14
3.6
3.0
e6/l
0.4
0.4
0.32
1454
9633
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
66
81
8.22
49.96
1.5
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
63
74
8.59
49.40
2.2
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1780
12757
1.55
49.28
3.5
2.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4910
43469
1.59
48.67
29.8
14.9
%
13.8
13.5
24.29
4877
42546
(3008757) Leukocyte morphology finding [Identifier] in Blood
157
440
3.63
47.66
3.5
4.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1851
13463
1.53
47.57
3.9
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2239
16987
1.49
46.85
3.8
3.2
ng/l
39.0
76.5
0.64
1424
10403
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1630
11572
1.55
46.61
3.1
2.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
101
206
4.97
46.56
2.0
1.9
umol/l
1.9
1.9
0.05
95
192
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1550
10908
1.56
45.99
2.2
1.8
mg/l
1.2
1.1
0.75
1191
8159
(3026008) Bacteria identified in Urine by Culture
1767
12816
1.53
45.63
3.4
2.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
420
2023
2.15
44.70
1.1
1.1
—
—
—
0
0
(4062490)
170
523
3.31
44.69
1.3
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
169
520
3.31
44.42
1.3
1.4
g/l
0.4
0.4
0.11
115
370
(3027135) IgG subclass 1 [Mass/volume] in Serum
169
521
3.31
44.28
1.3
1.4
g/l
8.1
6.7
2.94
116
373
(3028192) IgG subclass 2 [Mass/volume] in Serum
169
521
3.31
44.28
1.3
1.4
g/l
3.1
2.9
0.54
116
375
(3026782) Osmolality of Urine
1325
9070
1.58
44.10
3.1
2.7
mosm/kgh2o
539.3
554.1
1.48
1183
7732
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
146
411
3.61
44.04
1.1
1.1
mg/l
282.0
284.4
0.12
132
374
(3015377) Calcium [Moles/volume] in Serum or Plasma
2023
15188
1.49
43.87
3.4
3.3
mmol/l
2.3
2.4
4.00
1808
13474
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
817
4986
1.73
42.51
3.9
4.5
u/l
224.2
240.6
3.73
771
4728
(3019225) pH of Specimen
724
4296
1.77
41.51
4.4
4.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
47
49
9.66
40.33
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4137
35890
1.45
39.88
5.1
3.0
u/l
55.4
44.8
11.54
3925
33919
(3022217) INR in Platelet poor plasma by Coagulation assay
855
5414
1.67
38.55
22.6
21.2
inr
1.2
1.3
0.19
195
814
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
103
250
4.17
38.31
1.1
1.1
miu/ml
1480.6
1475.8
0.01
103
250
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
304
1380
2.26
37.39
4.4
4.8
mg/l
1.5
1.4
0.30
284
1294
(4035726)
662
3943
1.76
37.27
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5763
53996
1.82
36.66
22.0
11.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
888
5750
1.63
36.54
2.0
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
374
1872
2.06
35.87
1.8
1.7
g/l
1.5
1.5
0.27
327
1614
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
327
1558
2.16
35.69
1.6
1.7
g/l
1.2
1.2
0.45
309
1480
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
776
4889
1.67
35.49
2.1
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
318
1504
2.17
35.36
1.6
1.7
g/l
0.2
0.2
2.72
298
1428
(3052592) Norovirus Ag [Presence] in Stool
48
61
7.92
35.32
2.0
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
336
1630
2.12
35.01
2.1
2.0
ug/l
6.0
2.2
0.44
306
1455
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
254
1098
2.37
35.00
1.8
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
670
4128
1.70
33.22
5.3
4.2
mmol/l
1.7
1.9
0.58
520
3358
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
759
4836
1.65
33.09
2.0
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
218
909
2.45
32.55
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
78
174
4.53
32.37
1.3
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1156
8167
1.51
32.07
1.3
1.3
u/ml
6.4
11.0
2.37
421
3310
(3021447) Carbon dioxide [Partial pressure] in Venous blood
664
4139
1.68
31.43
5.4
4.2
kpa
5.8
5.9
0.71
640
4008
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
83
200
4.19
31.22
1.2
1.1
u/l
14.6
25.5
2.22
71
155
(3015171) Extractable nuclear Ab [Units/volume] in Serum
372
1960
1.95
30.83
1.3
1.2
u/ml
0.5
1.1
1.19
19
178
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1202
8634
1.49
30.58
1.3
1.3
iu/ml
22.9
32.5
1.94
365
2651
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
491
2835
1.79
30.54
4.9
3.7
kpa
5.1
5.2
1.05
454
2648
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
78
183
4.30
30.38
3.8
2.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
82
200
4.14
30.36
1.2
1.1
u/l
70.7
85.2
1.17
74
161
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
66
141
4.72
28.90
1.3
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
684
4398
1.62
28.53
9.2
8.1
%
96.0
95.9
0.19
658
4243
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
59
117
5.08
28.18
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
349
1855
1.93
28.17
2.2
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
851
5776
1.55
28.13
1.6
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
474
2778
1.76
27.97
6.0
4.7
—
—
—
0
0
(3009343) pH of Capillary blood
476
2803
1.76
27.62
5.0
3.7
ph
7.4
7.4
0.14
73
339
(3023183) Ammonium ion [Moles/volume] in Plasma
220
993
2.26
27.45
4.0
3.0
umol/l
30.9
35.5
2.38
192
858
(3002173) Hemoglobin [Mass/volume] in Arterial blood
641
4095
1.63
27.40
9.5
8.5
g/l
120.9
123.2
1.97
618
3951
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
379
2089
1.87
27.37
1.8
2.0
u/l
38.8
39.3
0.23
319
1897
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
709
4647
1.59
27.25
3.7
3.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
743
4934
1.57
26.99
8.8
7.6
mmol/l
0.8
0.9
0.49
566
3851
(3016650) Hepatitis A virus Ab [Presence] in Serum
205
906
2.31
26.89
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
602
3812
1.64
26.63
9.9
9.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
78
203
3.88
26.48
2.4
1.9
umol/l
27.0
29.9
1.32
78
193
(3008152) Bicarbonate [Moles/volume] in Arterial blood
452
2659
1.75
26.30
8.3
6.8
mmol/l
23.9
24.4
2.15
427
2476
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
459
2715
1.75
26.20
5.0
3.7
mmol/l
1.3
1.7
1.32
343
2013
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
232
1091
2.17
26.18
1.9
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
433
2524
1.77
26.00
1.1
1.1
titre
36.0
168.6
—
5
83
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
739
4942
1.56
25.98
8.8
7.6
kpa
5.0
5.1
3.68
707
4730
(3027801) Oxygen [Partial pressure] in Arterial blood
738
4943
1.56
25.75
8.8
7.6
kpa
12.5
12.7
0.42
707
4729
(3007461) Platelets [#/volume] in Blood
6039
58108
2.02
25.70
38.4
17.9
e9/l
270.8
253.2
65.75
5986
56714
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
116
397
2.96
25.60
1.1
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
519
3210
1.67
25.12
4.1
4.1
ng/l
89.9
87.7
0.18
457
2821
(3024731) MCV [Entitic volume]
6040
58158
2.01
25.06
38.2
17.8
fl
91.4
90.4
43.71
6011
57427
(3035941) MCH [Entitic mass]
6040
58159
2.01
25.05
38.1
17.8
pg
30.4
30.2
7.17
6010
57425
(3013512) EKG study
1613
12602
1.38
24.99
3.6
3.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
6040
58171
2.00
24.84
38.3
17.9
e12/l
4.5
4.6
38.87
5975
56657
(3010813) Leukocytes [#/volume] in Blood
6041
58191
2.00
24.72
38.4
17.9
e9/l
6.9
6.7
14.04
5980
56649
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
314
1686
1.91
24.58
2.1
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
6040
58189
1.99
24.54
38.5
18.0
g/l
134.8
137.2
33.06
6011
57450
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
180
785
2.33
24.37
1.8
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1735
13805
1.35
23.70
2.4
2.1
u/l
248.9
222.5
0.22
1643
13010
(1616796) Gas panel - Central venous blood
212
1011
2.14
23.12
3.8
3.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
255
1313
1.98
22.59
1.9
2.0
mg/l
11.1
10.6
0.46
225
1233
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1063
7864
1.42
22.39
3.0
2.6
e6/l
0.8
1.1
1.79
643
4373
(3020717) Zinc [Moles/volume] in Serum or Plasma
83
254
3.30
22.17
1.7
1.5
umol/l
21.4
25.7
0.69
78
240
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1440
11232
1.37
22.08
3.3
3.0
ng/l
1404.0
1235.6
0.63
1216
9437
(3011412) CD3 cells [#/volume] in Blood
133
529
2.55
22.05
2.0
2.4
e9/l
1.2
1.1
0.09
70
317
(3027315) Oxygen [Partial pressure] in Blood
215
1051
2.08
21.99
4.2
4.2
kpa
8.8
8.7
0.39
207
1033
(3015235) Bicarbonate [Moles/volume] in Capillary blood
219
1079
2.07
21.93
4.7
3.2
mmol/l
24.1
24.7
1.23
186
946
(3012501) Base excess in Blood by calculation
214
1046
2.08
21.89
4.2
4.2
mmol/l
2.3
2.4
0.23
146
687
(3013290) Carbon dioxide [Partial pressure] in Blood
214
1047
2.08
21.84
4.2
4.2
kpa
5.0
5.0
0.89
206
1030
(3047181) Lactate [Moles/volume] in Blood
263
1385
1.94
21.83
7.6
5.8
mmol/l
1.4
1.3
0.83
236
1222
(3026493) Urate [Moles/volume] in Serum or Plasma
1576
12508
1.35
21.50
3.0
2.5
umol/l
2967.7
3791.2
0.48
1412
11014
(3014111) Lactate [Moles/volume] in Serum or Plasma
597
3965
1.56
21.46
8.1
7.5
mmol/l
1.4
1.4
0.21
576
3802
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
384
2289
1.72
21.27
5.3
4.7
mmol/l
24.0
24.1
0.33
352
2070
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
104
372
2.83
21.25
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
104
372
2.83
21.25
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
104
372
2.83
21.25
1.5
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
147
624
2.39
21.21
1.8
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
551
3615
1.57
20.89
4.6
3.7
mmol/l
1.2
1.2
1.45
494
3154
(3011397) Hemoglobin [Presence] in Urine by Test strip
1408
11076
1.35
20.16
4.4
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
572
3824
1.55
19.93
3.2
2.5
ml/min/173m2
69.2
70.7
0.36
247
1433
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
257
1385
1.89
19.92
2.7
2.7
—
—
—
0
0
(3010421) pH of Blood
234
1228
1.94
19.65
4.2
4.2
ph
7.4
7.4
0.28
206
1030
(3005322) IgE [Units/volume] in Serum or Plasma
522
3432
1.57
19.58
1.3
1.3
u/ml
235.5
223.4
0.07
483
3182
(3004588) Protein electrophoresis panel - Serum or Plasma
429
2699
1.63
19.34
2.1
2.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
457
2921
1.61
19.32
8.7
7.8
mmol/l
24.5
24.8
0.71
447
2905
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
170
804
2.15
18.99
1.7
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
278
1561
1.82
18.92
2.0
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
550
3689
1.54
18.85
4.4
3.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
191
950
2.04
18.69
2.7
2.4
%
16.5
16.7
0.21
96
469
(3034274) Bile acid [Moles/volume] in Serum --fasting
165
777
2.15
18.65
2.1
2.5
umol/l
13.4
6.2
2.65
125
568
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4113
37484
1.28
18.45
3.3
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
984
7408
1.39
18.40
3.2
2.8
e6/l
2.9
2.5
0.37
573
3931
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
135
589
2.32
18.35
1.6
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
159
743
2.17
18.33
1.5
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
101
385
2.65
18.32
2.1
2.6
e6/l
485.7
528.0
0.37
87
317
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
124
522
2.40
18.28
1.5
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1127
8703
1.36
17.95
3.9
3.5
ng/l
416.6
576.5
0.43
778
6237
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
414
2632
1.61
17.88
1.6
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
149
689
2.19
17.64
1.6
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
505
3385
1.53
17.33
2.3
2.6
g/l
66.7
66.8
0.03
473
3118
(3018677) aPTT in Platelet poor plasma by Coagulation assay
933
7046
1.38
17.01
2.8
2.3
s
30.1
29.8
0.97
898
6851
(3028626) Oxygen [Partial pressure] in Capillary blood
206
1090
1.92
16.92
6.3
3.5
kpa
8.6
8.6
0.17
187
1013
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
136
621
2.22
16.64
1.6
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
95
371
2.58
16.46
2.1
2.7
e9/l
0.2
0.2
2.41
83
314
(40768443) Skin Pathology biopsy report
328
2012
1.66
16.34
1.3
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
59
179
3.32
16.08
1.7
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
114
491
2.35
16.02
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
500
3401
1.51
16.00
4.6
3.7
kpa
4.5
4.7
1.21
480
3282
(3019150) Specific gravity of Urine by Refractometry
1309
10492
1.31
15.94
5.0
3.6
kg/l
1.0
1.0
0.29
181
1515
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
372
2371
1.60
15.90
12.9
10.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1013
7842
1.35
15.67
3.1
2.9
mmol/l
2.4
2.4
0.93
883
6858
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
65
217
3.02
15.14
1.6
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
65
217
3.02
15.14
1.6
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
65
217
3.02
15.14
1.6
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
65
217
3.02
15.14
1.6
1.9
—
—
—
0
0
(44806118)
123
562
2.21
15.06
1.7
1.5
—
—
—
0
0
(44790049)
123
562
2.21
15.06
1.7
1.5
—
—
—
0
0
(44790047)
123
562
2.21
15.06
1.7
1.5
—
—
—
0
0
(44790048)
123
562
2.21
15.06
1.7
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
183
969
1.92
15.04
9.1
6.7
mmol/l
11.8
11.4
0.84
168
870
(3018572) Chloride [Moles/volume] in Blood
183
970
1.91
14.99
9.1
6.7
mmol/l
104.9
105.2
0.49
168
871
(3028433) Virus identified in Specimen by Culture
53
158
3.37
14.87
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
128
599
2.16
14.78
8.0
6.8
mg/l
11.7
11.3
0.29
117
558
(44816559) Phosphatidylethanol [Mass/volume] in Blood
206
1144
1.83
14.60
1.2
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
189
1022
1.88
14.58
1.2
1.2
u/ml
2.4
3.1
0.18
20
64
(3043409) Potassium [Moles/volume] in Arterial blood
224
1277
1.78
14.56
4.3
4.2
mmol/l
3.8
3.9
1.20
214
1197
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1384
11300
1.29
14.47
1.6
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
94
390
2.43
14.40
2.2
2.6
e6/l
769.3
730.9
0.18
50
152
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
107
471
2.29
14.34
1.6
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
251
1492
1.71
14.10
4.2
3.9
mmol/l
1.4
1.4
0.10
246
1468
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
378
2492
1.55
13.98
1.7
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
5152
48862
1.30
13.96
24.9
13.1
%
40.1
40.5
2.79
3730
37843
(3026389) Candida sp identified in Specimen by Organism specific culture
138
682
2.05
13.84
1.5
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
123
583
2.13
13.78
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
51
156
3.29
13.77
2.3
3.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
103
455
2.28
13.71
4.5
3.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
60
203
2.97
13.69
2.7
4.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
323
2066
1.59
13.62
5.5
3.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
316
2011
1.60
13.61
4.8
3.4
mmol/l
24.5
25.3
3.29
303
1945
(3030981) Hyaline casts [#/volume] in Urine by Automated count
352
2301
1.56
13.52
3.2
2.6
e6/l
0.4
0.3
0.76
342
2234
(3051651) Icteric interference index of Serum or Plasma
76
294
2.60
13.50
4.3
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
235
1391
1.72
13.42
4.3
3.6
u/ml
0.3
0.3
0.60
141
785
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
505
3567
1.45
13.35
2.8
2.2
ug/l
5.6
7.8
2.37
451
3176
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
238
1416
1.71
13.34
1.3
1.2
u/ml
10.2
37.8
2.70
16
84
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
220
1286
1.74
13.15
1.3
1.2
u/ml
14.4
5.8
0.51
31
116
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
221
1303
1.72
12.82
1.3
1.3
u/ml
9.3
8.0
0.18
46
188
(21494815) CD4 cells/100 lymphocytes in Specimen
103
472
2.20
12.59
2.0
2.4
%
52.2
42.9
1.13
18
57
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
287
1824
1.60
12.46
5.5
3.9
mmol/l
24.6
24.8
0.77
272
1708
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
109
516
2.13
12.30
2.0
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
273
1721
1.61
12.26
7.3
5.0
%
1.8
1.7
0.52
257
1608
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
243
1494
1.65
12.06
1.1
1.1
u/ml
9.7
5.8
0.34
27
224
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
248
1534
1.64
12.02
3.9
3.0
g/l
3.4
3.5
0.98
231
1455
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
77
319
2.43
11.90
1.9
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4200
39142
1.22
11.90
4.0
3.9
pmol/l
14.7
14.6
2.33
3862
35978
(3034860) Kappa light chains.free [Mass/volume] in Serum
200
1177
1.72
11.71
2.6
3.5
mg/l
44.0
55.9
0.99
161
964
(3007930) Methemoglobin/Hemoglobin.total in Blood
269
1710
1.60
11.68
7.3
5.0
%
1.0
0.9
1.94
253
1603
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
169
948
1.80
11.67
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
159
876
1.84
11.64
2.5
3.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
200
1179
1.72
11.64
2.5
3.5
mg/l
34.3
60.1
1.37
160
969
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
93
423
2.22
11.62
1.7
2.2
%
11.0
14.1
1.37
46
213
(3020891) Body temperature
270
1723
1.59
11.54
5.9
4.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
144
773
1.88
11.45
1.9
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
144
773
1.88
11.45
4.5
2.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
45
146
3.10
11.10
1.6
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4901
46530
1.24
11.06
4.8
4.5
mu/l
1.7
2.1
3.71
4568
43182
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
88
402
2.21
10.90
1.8
2.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
191
1144
1.69
10.52
2.5
3.5
ratio
1.5
2.1
0.47
19
90
(36660697) Celiac disease serology panel - Serum
561
4212
1.36
10.40
1.2
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
60
237
2.55
10.31
1.5
1.3
u/l
355.0
363.0
0.02
51
221
(3012516) Albumin [Mass/volume] in Urine
1500
12811
1.22
10.04
3.6
3.3
mg/l
524.3
356.1
0.65
1041
8270
(3006184) Hemoglobin [Mass/volume] in Capillary blood
166
974
1.72
9.88
2.6
2.2
g/l
129.1
131.8
0.78
134
712
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
39
125
3.13
9.85
1.2
1.3
nmol/l
145.8
139.9
0.06
25
94
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
36
111
3.26
9.69
1.1
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
32
92
3.49
9.59
2.8
3.0
—
—
—
0
0
(3002256) Pathology report gross observation
779
6202
1.29
9.57
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
226
1449
1.58
9.53
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
3638
33792
1.18
9.35
3.9
3.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
37
119
3.12
9.31
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
238
1556
1.55
9.23
2.1
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
238
1557
1.55
9.20
2.1
2.3
g/l
7.2
7.3
0.57
179
1186
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
213
1363
1.58
9.07
1.8
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
50
193
2.60
9.05
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
226
1468
1.56
9.02
2.1
2.4
g/l
3.1
3.1
0.12
172
1158
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
237
1556
1.54
9.02
2.1
2.3
g/l
3.8
3.8
0.11
169
1128
(3020682) Albumin/Creatinine [Ratio] in Urine
1552
13437
1.21
8.88
4.3
4.0
mg/mmol
8.5
9.8
0.56
1051
8724
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
148
872
1.71
8.73
1.5
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
143
837
1.72
8.64
3.7
3.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
250
1683
1.51
8.49
3.1
2.6
%
92.4
92.7
0.06
236
1573
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
16
29
5.53
8.49
1.3
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
219
1434
1.55
8.46
2.1
2.4
g/l
10.3
10.4
0.01
182
1234
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
71
331
2.16
8.46
2.0
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
46
177
2.61
8.40
1.7
2.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
453
3409
1.35
8.29
3.5
2.9
ng/l
202.2
176.6
0.49
408
3061
(3003181) Sodium [Moles/volume] in Urine
125
713
1.77
8.29
1.7
1.4
mmol/l
64.7
65.6
0.06
72
570
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
63
284
2.23
8.17
3.0
2.5
u/ml
1523.9
1266.4
0.19
63
284
(3004119) Hemoglobin [Mass/volume] in Venous blood
363
2646
1.39
8.10
4.9
3.5
g/l
127.5
130.8
1.91
347
2576
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
45
176
2.57
7.97
1.7
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
45
176
2.57
7.97
1.7
2.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
227
1519
1.51
7.96
3.6
2.8
%
185.6
182.6
0.22
214
1453
(3009508) Creatinine [Moles/volume] in Urine
1659
14599
1.19
7.75
3.5
3.3
mmol/l
8.0
8.0
0.13
1445
12481
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
171
1081
1.60
7.73
1.3
1.2
u/ml
44.1
46.0
0.05
25
101
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
36
128
2.82
7.67
1.4
1.6
ug/l
11.8
8.6
2.01
36
128
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
29
91
3.20
7.65
1.7
1.5
ug/l
0.4
0.4
0.07
20
58
(4010399)
433
3284
1.34
7.54
1.5
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
27
84
3.22
7.23
1.7
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
79
409
1.94
7.16
1.6
1.5
%
26.8
32.3
0.71
54
256
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
72
361
2.01
7.15
1.5
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
42
171
2.47
6.90
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
52
234
2.23
6.83
1.4
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
180
1188
1.53
6.79
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
337
2508
1.36
6.67
2.3
2.3
u/l
4266.3
5707.9
0.37
103
987
(3039162) Centromere protein B Ab [Units/volume] in Serum
107
624
1.73
6.65
1.2
1.3
u/ml
4.2
49.8
—
7
34
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
46
199
2.32
6.63
3.2
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
291
2125
1.39
6.48
2.0
1.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
272
1972
1.40
6.33
4.3
3.1
%
0.7
0.7
1.38
262
1889
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
286
3857
0.73
6.30
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
95
545
1.75
6.28
3.0
2.6
—
—
—
0
0
(3036489) Thrombin time
267
1933
1.40
6.27
2.9
2.4
s
21.6
21.4
0.16
235
1675
(3022621) pH of Urine by Test strip
392
3020
1.32
6.17
3.5
2.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
194
1338
1.46
5.96
2.1
2.4
g/l
0.6
0.9
0.89
172
1176
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
90
518
1.75
5.91
1.7
1.6
%
53.5
57.5
0.40
61
328
(3006653) Thiamine [Moles/volume] in Blood
52
249
2.10
5.91
1.3
1.3
nmol/l
135.4
134.8
0.04
52
249
(3001186) Copper [Moles/volume] in Serum or Plasma
32
124
2.59
5.86
1.2
1.3
umol/l
16.7
16.9
0.08
27
109
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
62
319
1.95
5.80
1.4
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
144
939
1.55
5.80
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
144
939
1.55
5.80
1.6
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
45
206
2.19
5.73
1.6
2.0
—
—
—
0
0
(3024471) HLA-A [Type]
44
200
2.21
5.70
1.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
51
246
2.08
5.70
1.1
1.1
iu/ml
3.2
4.2
—
5
19
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
177
1213
1.47
5.64
2.1
2.2
g/l
38.1
38.0
0.09
156
1063
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
17
46
3.70
5.63
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
163
1099
1.50
5.63
2.2
2.3
g/l
0.0
0.0
0.00
152
1018
(3024932) HLA-DR beta [Type]
43
196
2.20
5.55
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
124
790
1.58
5.54
1.4
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
161
1087
1.49
5.53
2.2
2.3
g/l
0.0
0.0
0.00
151
1016
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
53
264
2.02
5.45
1.1
1.1
u/ml
12.0
23.2
—
7
23
(1761868) Lipid panel - Serum or Plasma
1803
19818
0.87
5.43
2.5
2.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
41
185
2.22
5.43
1.3
1.2
g/l
0.3
0.3
0.48
30
152
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
173
1190
1.47
5.42
2.2
2.2
g/l
0.0
0.0
0.23
162
1104
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
307
2329
1.33
5.41
11.7
10.2
mmol/l
23.9
24.2
1.14
287
2193
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
668
5577
1.22
5.38
10.8
6.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
44
206
2.14
5.33
8.4
6.2
mg/l
4699.8
69.0
0.49
36
147
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
17
48
3.55
5.32
1.7
1.6
mg/l
2.8
1.6
0.34
11
26
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
11
22
5.01
5.26
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
40
182
2.21
5.20
4.1
3.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
210
1510
1.40
5.20
2.4
2.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
44
209
2.11
5.15
1.4
1.5
%
4.2
3.9
0.05
14
49
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
16
45
3.56
5.04
1.8
1.5
mg/l
0.9
3.5
—
10
29
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
16
45
3.56
5.04
1.7
1.5
mg/l
0.5
2.1
1.50
11
28
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
16
45
3.56
5.04
1.7
1.5
mg/l
0.4
1.2
1.29
11
27
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
16
45
3.56
5.04
1.7
1.5
mg/l
1.7
4.5
—
6
26
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
16
45
3.56
5.04
1.7
1.5
mg/l
2.8
1.5
—
7
25
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
16
45
3.56
5.04
1.7
1.5
mg/l
1.4
2.2
—
10
28
(3000093) Morphology [Interpretation] in Blood Narrative
74
423
1.76
5.03
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
51
261
1.96
4.90
1.6
1.5
nmol/l
1.1
1.3
0.61
43
199
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
36
161
2.24
4.90
1.6
1.9
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
12
28
4.29
4.82
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
447
3619
1.25
4.81
2.3
2.3
au/ml
21.7
22.1
0.02
27
231
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
151
2161
0.69
4.80
1.7
1.7
mg/l
3.1
3.8
0.83
113
1493
(21494755) Public health laboratory ask at order entry panel
550
6598
0.82
4.80
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
869
7514
1.18
4.79
1.8
1.8
%
1.4
1.4
0.25
742
6739
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
20
5.01
4.77
1.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
34
151
2.26
4.71
1.4
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
467
5686
0.81
4.71
1.5
1.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
38
177
2.15
4.70
1.8
2.4
e6/l
171.8
180.0
0.07
22
93
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
74
2.84
4.64
2.3
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
215
1584
1.37
4.64
3.1
3.2
g/l
0.3
0.3
0.20
108
695
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
45
225
2.01
4.64
2.1
2.4
umol/l
89.9
160.5
1.52
28
124
(3044927) Protein electrophoresis panel - Urine
66
376
1.76
4.58
1.1
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
50
261
1.92
4.57
2.0
1.4
u/ml
21.2
20.3
—
9
54
(3021788) Differential panel - Synovial fluid
122
812
1.51
4.56
1.5
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
215
1589
1.37
4.56
2.8
2.4
ug/l
434.7
622.1
0.49
193
1491
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
37
173
2.15
4.55
1.3
1.2
%
107.4
110.1
0.22
31
152
(3000475) Leukocytes [#/volume] in Synovial fluid
152
1059
1.45
4.53
1.8
1.7
e6/l
9756.3
14423.7
1.18
120
764
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
45
229
1.97
4.43
1.3
1.6
u/field
2.2
3.8
0.78
38
174
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
203
1495
1.37
4.41
1.2
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
20
71
2.82
4.38
1.1
1.1
pmol/l
5.7
5.8
—
6
8
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
213
1584
1.36
4.36
1.3
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
86
535
1.62
4.33
2.9
2.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
409
3322
1.25
4.31
1.3
1.3
au/ml
50.4
48.5
0.04
13
139
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
960
8442
1.16
4.28
1.5
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
56
311
1.81
4.25
2.3
2.7
%
38.9
40.3
0.12
18
102
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
121
817
1.49
4.25
1.1
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
12
31
3.88
4.25
1.8
6.5
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
12
31
3.88
4.25
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
145
1015
1.44
4.24
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
25
102
2.46
4.20
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
37
179
2.07
4.19
2.5
2.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
41
3.42
4.18
1.0
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
20
73
2.75
4.17
1.8
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
89
564
1.59
4.17
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
121
821
1.48
4.16
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
67
397
1.70
4.09
1.3
1.4
e6/l
243900.2
76356.4
0.61
48
276
(3002523) Influenza virus A Ag [Presence] in Specimen
144
1015
1.43
4.07
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
64
376
1.71
4.03
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
38
189
2.02
4.02
1.4
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
101
666
1.52
3.99
1.3
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
82
517
1.59
3.95
2.7
2.0
mg/l
25.3
21.2
0.27
28
137
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
28
125
2.25
3.89
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
120
826
1.46
3.87
1.1
1.1
u/ml
2.5
3.8
1.19
44
422
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
27
119
2.27
3.86
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
122
843
1.46
3.85
1.3
1.2
u/ml
5.1
3.8
0.38
61
273
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
105
705
1.50
3.83
2.5
2.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
120
829
1.46
3.80
1.3
1.2
u/ml
3.9
4.2
0.12
71
366
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
57
332
1.72
3.73
1.1
1.1
ratio
1.0
1.1
0.10
22
115
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
118
819
1.45
3.66
1.1
1.1
%
123.3
114.8
2.17
110
746
(3011985) Renin [Units/volume] in Plasma
94
624
1.51
3.64
1.5
1.5
mu/l
75.1
59.8
0.33
81
555
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
44
239
1.85
3.64
2.2
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
36
183
1.97
3.62
2.3
2.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
44
240
1.84
3.59
2.2
2.3
umol/l
15.1
21.6
—
5
22
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
270
1.78
3.56
2.1
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
97
653
1.49
3.53
1.6
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
24
105
2.29
3.51
2.0
2.3
—
—
—
0
0
(4268621)
87
573
1.53
3.51
2.5
2.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
41
3.18
3.49
1.5
4.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
358
2938
1.23
3.49
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
17
63
2.70
3.48
1.7
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
750
6576
1.16
3.48
1.4
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
40
214
1.87
3.48
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1624
14961
1.12
3.48
1.5
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
66
409
1.62
3.45
1.3
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
19
75
2.54
3.45
2.2
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
41
222
1.85
3.44
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
66
410
1.62
3.42
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
639
5545
1.17
3.39
4.0
4.1
%
32.1
31.6
0.44
485
3907
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
43
238
1.81
3.37
2.2
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
68
428
1.60
3.35
1.4
1.3
nmol/l
1.6
1.4
0.52
57
386
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
66
413
1.60
3.33
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
66
413
1.60
3.33
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
66
414
1.60
3.31
1.3
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
48
277
1.74
3.29
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
129
930
1.40
3.29
1.6
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
43
3.03
3.24
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
65
409
1.60
3.22
1.3
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
49
2.86
3.18
1.4
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
260
2083
1.26
3.17
1.1
1.1
u/ml
53.4
1.8
—
7
29
(3047007) Chlamydophila sp Ab [Presence] in Serum
115
819
1.41
3.16
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
63
400
1.58
3.03
1.7
2.1
—
—
—
0
0
(4306422)
118
852
1.39
3.01
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
49
293
1.68
2.99
1.3
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
83
563
1.48
2.97
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
36
198
1.82
2.92
1.0
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
17
4.71
2.91
1.0
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
10
30
3.34
2.90
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
79
534
1.49
2.88
1.1
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
56
351
1.60
2.86
1.8
1.4
—
70.1
—
0
40
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
59
375
1.58
2.85
1.2
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
46
275
1.68
2.83
1.6
1.6
u/l
13.4
12.9
0.17
46
265
(3003338) MCHC [Mass/volume]
4685
45676
1.10
2.81
31.6
15.4
g/l
331.8
333.3
25.01
4674
45337
(3017704) Immunofixation for Urine
39
223
1.75
2.80
1.9
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
16
65
2.47
2.78
1.4
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
347
2912
1.20
2.77
1.4
1.4
iu/l
26.8
25.6
0.28
308
2476
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
21
98
2.15
2.70
3.0
3.3
u/l
35.6
43.5
—
5
29
(3019977) pH of Arterial blood
39
226
1.73
2.69
2.6
3.0
ph
7.4
7.4
0.53
13
72
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
49
303
1.62
2.67
1.2
1.5
u/l
5.2
6.5
1.03
38
262
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
765
8523
0.88
2.65
2.8
2.8
ug/l
0.7
0.7
0.95
506
5248
(3040151) Glucose [Moles/volume] in Capillary blood
75
513
1.47
2.61
6.9
6.8
mmol/l
7.0
7.3
0.27
62
430
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
57
368
1.55
2.60
1.1
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
9
25
3.60
2.57
3.1
2.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
53
338
1.57
2.56
1.4
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
39
230
1.70
2.55
1.7
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
34
193
1.77
2.53
1.6
1.4
—
—
—
0
0
(4015189)
21
101
2.08
2.52
1.9
2.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
16
70
2.29
2.40
1.9
1.7
ng/l
128.7
118.7
0.11
16
70
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
6
12
5.00
2.40
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
818
7402
1.12
2.39
2.1
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
39
235
1.66
2.38
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
48
307
1.57
2.32
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
163
1.78
2.26
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
102
1356
0.75
2.25
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
265
2219
1.20
2.22
2.5
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
241
2002
1.21
2.20
1.3
1.3
miu/ml
225.4
219.1
0.08
94
947
(3050794) Legionella sp Ab [Presence] in Serum
12
48
2.50
2.18
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
137
1070
1.29
2.16
2.6
2.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
82
594
1.39
2.15
1.2
1.3
—
—
—
0
0
(4024509)
58
394
1.48
2.15
1.3
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
107
1400
0.76
2.12
1.5
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
65
453
1.44
2.12
1.3
1.4
mmol/l
10.2
12.1
1.25
21
109
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
17
81
2.10
2.12
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
168
2078
0.80
2.11
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
104
1362
0.76
2.08
1.4
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
36
221
1.63
2.08
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
24
131
1.84
2.07
2.0
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
70
498
1.41
2.05
1.2
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
22
118
1.87
2.01
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
22
118
1.87
2.01
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
22
118
1.87
2.01
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
22
118
1.87
2.01
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
96
723
1.33
2.00
1.9
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
36
224
1.61
1.99
1.1
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
141
1.78
1.96
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
163
1320
1.24
1.94
1.3
1.4
mg/l
466.2
502.2
0.52
154
1256
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
25
142
1.76
1.92
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
80
592
1.36
1.88
1.3
1.4
pmol/l
348.2
269.7
1.17
65
454
(3045683) HLA typing for celiac disease panel - Blood or Tissue
50
340
1.47
1.88
1.0
1.0
—
—
—
0
0
(4211845)
36
228
1.58
1.87
3.3
2.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
60
425
1.42
1.84
2.5
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
111
865
1.29
1.83
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
17
3.53
1.83
1.5
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
12
4.17
1.82
1.2
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
887
8186
1.10
1.81
2.2
2.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
39
254
1.54
1.80
1.0
1.1
%
98.4
94.2
0.50
30
199
(3042111) Morphology [Interpretation] in Bone marrow Narrative
94
719
1.31
1.79
1.5
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
39
255
1.53
1.78
1.4
1.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
11
47
2.34
1.77
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
147
1.70
1.73
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
135
1666
0.81
1.72
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
84
637
1.32
1.71
3.3
3.1
nmol/l
0.9
0.8
0.27
63
484
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
135
1664
0.81
1.70
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
53
373
1.42
1.70
1.3
1.3
u/ml
0.2
0.9
1.09
23
150
(3016038) Potassium [Moles/volume] in Urine
41
275
1.49
1.68
1.7
1.2
mmol/l
32.2
34.6
0.23
34
241
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
136
1670
0.81
1.66
1.4
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
42
285
1.48
1.63
1.5
2.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
8
32
2.50
1.59
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
137
1671
0.82
1.59
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
228
1951
1.17
1.59
1.4
1.5
u/l
9.0
8.9
0.00
189
1586
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
23
137
1.68
1.54
1.1
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
107
1.78
1.54
1.4
1.1
%
77.3
69.8
—
8
28
(3048879) Bone marrow aspiration report
19
107
1.78
1.54
1.9
2.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
8
33
2.43
1.53
1.1
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
27
2.59
1.51
1.1
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
146
1.65
1.50
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
31
202
1.54
1.48
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
31
202
1.54
1.48
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
37
2.43
1.47
1.2
1.8
umol/l
34.0
46.5
—
9
37
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
22
133
1.66
1.42
3.0
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
22
133
1.66
1.42
3.0
3.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
43
303
1.42
1.42
1.1
1.1
nmol/l
2.1
6.9
—
8
61
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
140
1162
1.21
1.40
1.3
1.4
mmol/l
3.7
3.7
0.22
128
1091
(3006462) Nitrate [Presence] in Urine
31
205
1.51
1.40
3.2
3.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
17
96
1.77
1.38
1.1
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
131
1083
1.21
1.37
2.5
2.4
ug/min
75.9
114.5
0.71
76
694
(3006270) Folate [Moles/volume] in Blood
53
390
1.36
1.37
1.2
1.1
nmol/l
362.8
376.4
0.20
47
353
(3039744) RNA polymerase III Ab [Units/volume] in Serum
9
41
2.20
1.36
1.0
1.0
—
3.4
—
0
5
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
124
1021
1.22
1.35
2.6
2.2
nmol/l
1.1
0.8
2.13
102
865
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
68
1.91
1.33
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
571
5247
1.10
1.32
1.5
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
54
2.04
1.32
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
207
1790
1.16
1.31
1.5
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
113
1.68
1.31
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
61
464
1.32
1.29
1.6
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
10
48
2.09
1.27
1.3
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
62
1.94
1.27
1.1
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
38
268
1.42
1.27
2.4
2.2
min
506.6
488.7
0.56
29
201
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
55
2.00
1.27
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
341
0.64
1.26
1.8
1.6
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
18
107
1.68
1.25
1.3
1.1
%
76.1
76.0
—
7
29
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
154
1807
0.85
1.24
1.5
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
45
329
1.37
1.23
2.6
2.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
28
187
1.50
1.23
2.5
2.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
62
477
1.30
1.22
1.8
1.4
promille
1.2
1.4
0.51
45
364
(3039443) Prostate specific Ag panel - Serum or Plasma
85
1054
0.80
1.22
1.5
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
18
109
1.65
1.18
1.4
1.2
g/l
39.8
37.7
0.31
13
57
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1331
12694
1.06
1.17
1.8
1.6
mmol/l
1.4
1.4
0.37
1140
10861
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
138
1169
1.18
1.16
1.3
1.5
e6/l
24.0
23.8
0.01
108
906
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
138
1169
1.18
1.16
1.4
1.6
e6/l
750.7
4237.1
0.57
114
956
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
166
1.51
1.14
1.2
1.1
%
93.6
90.0
0.21
12
84
(3026692) Albumin [Mass/volume] in Peritoneal fluid
19
118
1.61
1.14
1.5
1.5
g/l
13.5
12.5
0.15
12
92
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
208
1823
1.15
1.14
1.5
1.5
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
30
2.33
1.12
1.3
1.8
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
24
159
1.51
1.11
1.2
1.2
%
94.6
88.8
0.21
12
81
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
51
1.96
1.11
1.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
28
192
1.46
1.11
1.5
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
43
319
1.35
1.10
1.2
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
358
3252
1.11
1.09
3.3
3.3
pmol/l
4.5
4.5
0.39
317
2901
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
21
2.38
1.09
1.4
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
12
66
1.82
1.08
1.2
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
26
177
1.47
1.07
1.2
1.5
pmol/l
15.0
14.8
0.06
20
149
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
33
2.12
1.05
1.3
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
19
121
1.57
1.05
1.1
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
60
757
0.79
1.04
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
92
760
1.21
1.04
1.2
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
46
1.96
1.03
2.0
2.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
87
718
1.21
1.00
2.0
1.9
titre
4613.3
1246.7
—
6
36
(40761995) Spermatozoa Progressive [#/volume] in Semen
16
250
0.64
1.00
4.7
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
16
250
0.64
1.00
9.4
5.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
67
538
1.25
0.99
1.2
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
43
326
1.32
0.98
2.3
2.1
u/field
1.5
1.7
0.30
31
143
(3029634) Reagin Ab [Titer] in Serum by VDRL
105
884
1.19
0.98
2.4
2.1
titre
20.6
8.8
—
7
20
(3015183) Erythrocyte sedimentation rate
42
318
1.32
0.97
1.1
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
9
50
1.80
0.96
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
100
1.60
0.96
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
106
896
1.19
0.96
1.2
1.1
au/ml
6.2
12.2
—
6
64
(3044941) Cell count panel - Synovial fluid
88
732
1.21
0.95
1.4
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
37
1.89
0.94
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
88
733
1.20
0.93
1.2
1.2
u/l
25.1
41.0
1.53
80
634
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
53
418
1.27
0.92
2.9
3.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
23
327
0.70
0.92
1.0
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
44
339
1.30
0.91
1.0
1.1
iu/ml
6.4
10.3
—
10
95
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
28
2.14
0.91
1.7
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
303
3312
0.91
0.87
1.7
1.7
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
30
2.00
0.87
1.3
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
56
450
1.25
0.85
1.3
1.2
—
—
—
0
0
(3036603) Volume of Urine
39
299
1.31
0.85
1.7
1.5
ml
2544.8
1996.1
—
5
57
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
12
72
1.67
0.85
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
282
1.31
0.84
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
222
1.35
0.83
1.7
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
222
1.35
0.83
1.7
1.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
33
248
1.33
0.83
1.9
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
216
1946
1.11
0.82
1.6
1.7
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
11
65
1.69
0.82
1.1
1.3
mmol/l
0.8
1.7
—
6
47
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
32
1.88
0.81
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
12
73
1.65
0.81
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
105
1.53
0.81
1.0
1.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
15
97
1.55
0.81
1.1
1.4
g/l
25.8
25.2
—
9
74
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
93
793
1.18
0.80
1.5
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
143
1261
1.14
0.79
1.5
1.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
16
235
0.68
0.78
2.2
2.0
ug/min
125.6
241.1
—
5
56
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
114
1309
0.87
0.78
1.2
1.1
u/ml
1.2
1.8
0.41
45
547
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
34
1.77
0.76
1.0
1.3
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
6
34
1.77
0.76
1.3
1.2
—
1.1
—
0
6
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
16
107
1.50
0.76
1.3
1.2
pmol/l
226.5
286.8
0.51
11
77
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
107
1.50
0.76
12.9
5.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
67
558
1.20
0.75
1.3
1.8
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
11
67
1.64
0.75
6.6
8.7
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
24
2.08
0.74
1.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
54
1.67
0.74
2.0
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
20
141
1.42
0.74
1.3
1.4
—
—
—
0
0
(4027681)
46
369
1.25
0.74
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
59
487
1.21
0.73
1.4
1.5
mosm/kgh2o
280.5
281.3
0.06
46
378
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
38
1.84
0.73
1.0
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
57
469
1.22
0.73
1.2
1.2
mg/l
40.6
40.6
0.00
50
395
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
21
150
1.40
0.73
2.0
2.0
e6/l
4332.1
16577.8
0.47
16
84
(3016018) Differential panel - Cerebral spinal fluid
69
579
1.19
0.73
1.3
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
17
242
0.70
0.72
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
112
979
1.15
0.72
5.4
3.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
110
0.55
0.71
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
88
1021
0.86
0.71
3.4
3.2
mg/l
24.1
25.1
0.08
49
619
(3017446) Testosterone [Moles/volume] in Serum or Plasma
470
4419
1.07
0.71
2.2
2.2
nmol/l
13.5
13.0
0.57
430
3954
(3002619) Bacteria identified in Specimen by Culture
14
93
1.51
0.69
1.6
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
628
5965
1.06
0.69
1.7
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
123
1087
1.13
0.68
1.4
1.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
27
1.85
0.68
6.4
4.3
—
—
—
0
0
(4198724)
27
352
0.77
0.67
1.7
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
128
1136
1.13
0.67
1.2
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
43
1.63
0.66
2.1
2.6
u/field
0.0
0.7
—
7
43
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
55
457
1.21
0.66
1.1
1.1
mg/l
231.1
261.1
1.00
49
404
(3005011) Chlamydia sp Ab [Titer] in Serum
12
78
1.54
0.65
1.7
1.4
—
—
—
0
0
(4281824)
38
472
0.80
0.65
1.1
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
107
942
1.14
0.64
1.4
1.5
nmol/l
0.4
0.4
0.06
87
757
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
259
2393
1.09
0.64
2.3
3.1
u/ml
59.9
49.8
0.21
250
2307
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
287
1.26
0.63
1.2
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
60
507
1.19
0.61
2.2
2.3
nmol/l
20.1
20.2
0.02
53
481
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
139
1250
1.11
0.60
1.8
1.9
iu/l
3.2
4.6
2.05
56
469
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
51
1.57
0.60
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
51
1.57
0.60
1.1
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
100
883
1.13
0.59
1.2
1.1
iu/ml
31.7
11103.0
0.56
27
219
(3000330) Specific gravity of Urine by Test strip
234
2163
1.08
0.59
4.0
3.1
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
0.7
—
0
16
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
123
1.38
0.57
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
54
1.48
0.57
1.1
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
8
54
1.48
0.57
2.9
2.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
41
496
0.83
0.57
1.6
1.6
mmol/l
7.7
7.6
0.02
23
314
(44813793)
47
392
1.20
0.56
1.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
36
1.67
0.56
1.7
2.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
65
1.54
0.55
1.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
21
159
1.32
0.55
1.0
1.1
u/ml
0.3
7.8
0.89
11
95
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
42
348
1.21
0.54
1.3
1.3
u/l
354.1
368.5
0.07
42
335
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
26
204
1.28
0.54
1.1
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
15
108
1.39
0.53
1.0
1.1
u/ml
0.1
8.9
—
10
78
(3028707) Methadone [Presence] in Urine by Screen method
118
1308
0.90
0.52
2.3
3.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
66
1.52
0.52
1.2
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
117
1.37
0.52
8.1
6.9
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(4212803)
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4580
45415
1.03
0.51
5.7
5.1
mmol/mol
39.1
39.1
0.01
4307
42566
(3018133) Calcium [Moles/volume] in Urine
13
92
1.41
0.50
1.6
2.5
mmol/l
1.5
2.6
—
8
86
(4146454)
51
435
1.17
0.50
2.4
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
183
1690
1.09
0.50
1.8
1.8
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
33
270
1.22
0.49
5.1
6.6
u/ml
30.0
9817.6
—
7
67
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1138
11706
0.97
0.49
4.1
3.8
%
21.0
21.7
0.87
517
5129
(3047189) Immunofixation for 24 hour Urine
24
189
1.27
0.49
1.8
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
26
207
1.26
0.49
1.6
1.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
42
353
1.19
0.49
2.3
2.3
ml
764.1
634.3
0.70
32
247
(3003888) Timothy IgE Ab [Units/volume] in Serum
107
1184
0.90
0.47
1.1
1.1
u/ml
5.8
6.4
0.15
52
632
(3044009) aPTT.lupus sensitive (LA screen)
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
7
48
1.46
0.46
1.1
1.4
%
76.9
72.0
—
7
41
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
111
1.35
0.46
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
53
458
1.16
0.46
3.2
2.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
49
421
1.17
0.45
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
118
1074
1.10
0.45
2.0
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
308
3256
0.94
0.45
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
219
2341
0.93
0.45
1.9
2.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
44
514
0.86
0.45
1.2
1.4
pmol/l
78.8
127.3
0.37
21
158
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
43
366
1.18
0.45
1.7
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
234
2195
1.07
0.44
2.0
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
265
2811
0.94
0.44
1.7
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
139
1.30
0.43
1.3
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
18
139
1.30
0.43
2.4
2.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
104
1144
0.91
0.43
1.1
1.1
u/ml
0.5
1.2
1.62
45
495
(3000034) Microalbumin [Mass/volume] in Urine
50
433
1.16
0.43
3.4
3.0
mg/l
29.3
61.8
1.10
40
320
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
131
0.69
0.43
1.3
1.8
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
32
1.56
0.42
1.0
1.5
umol/24h
241.0
333.5
—
5
32
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
70
1.43
0.41
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
20
158
1.27
0.41
1.2
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
2.3
—
0
16
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.2
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
15
114
1.32
0.40
1.5
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
38
324
1.17
0.40
1.1
1.1
u/l
1.1
1.1
0.14
19
157
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
54
474
1.14
0.39
3.1
2.2
mmol/l
4.1
4.0
0.22
54
466
(3035285) Chloride [Moles/volume] in Venous blood
54
474
1.14
0.39
3.1
2.2
mmol/l
106.0
105.6
0.26
54
466
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
56
493
1.14
0.39
3.0
4.8
u/ml
33.9
71.7
0.75
15
141
(3000764) Benzodiazepines [Presence] in Urine
287
3018
0.95
0.37
1.7
2.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
12
89
1.35
0.37
2.6
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
50
439
1.14
0.37
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
284
2986
0.95
0.37
1.7
2.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
304
3188
0.95
0.36
1.5
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
54
478
1.13
0.36
1.3
1.5
e6/l
2222.6
2308.0
0.04
42
349
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
38
328
1.16
0.36
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
74
817
0.90
0.35
1.2
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
82
1.34
0.34
10.3
7.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
290
3036
0.95
0.33
1.7
2.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
164
1.22
0.32
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
291
3042
0.95
0.32
1.7
2.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
24
201
1.19
0.32
2.6
2.5
mmol/l
8.7
9.4
0.43
15
150
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
128
1.25
0.31
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
70
767
0.91
0.30
1.4
1.4
mmol/l
7.3
7.1
0.20
48
561
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
29
249
1.17
0.30
1.5
1.6
nmol/l
4.8
5.0
0.02
23
199
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
84
1.31
0.30
1.0
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
41
363
1.13
0.29
1.0
1.1
u/ml
5.0
1.4
0.39
20
108
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
127
1193
1.07
0.28
1.5
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
177
1.19
0.27
13.9
10.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
85
917
0.93
0.27
1.2
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
65
1.23
0.27
8.4
11.1
mmol/l
4.3
6.2
—
8
65
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
2.5
2.5
pmol/l
88.7
68.8
—
8
56
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4816
48379
0.98
0.27
3.9
3.6
mmol/l
1.3
1.3
1.75
4483
45099
(3041806) Other cells [#/volume] in Blood by Manual count
30
262
1.15
0.26
1.6
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
104
1109
0.94
0.25
1.1
1.1
u/ml
1.8
2.2
0.12
25
276
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
14
114
1.23
0.25
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
14
114
1.23
0.25
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
14
114
1.23
0.25
1.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
9
75
1.20
0.25
1.0
1.0
—
—
—
0
0
(44806071)
9
75
1.20
0.25
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
105
1.24
0.24
8.8
7.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
144
1368
1.05
0.23
1.9
1.9
pmol/l
203.5
203.7
0.01
139
1295
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
44
399
1.10
0.23
1.2
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
37
411
0.90
0.23
1.5
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
125
0.80
0.23
2.3
2.2
umol/l
11.2
15.9
—
10
125
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
285
0.88
0.23
1.0
1.0
ng/l
304.5
330.9
0.28
19
204
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5058
50402
1.02
0.22
4.3
4.0
mmol/l
4.6
4.7
11.71
4748
47409
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
41
1.22
0.22
1.0
1.2
u/l
8.6
11.8
—
5
41
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
7.5
—
0.3
—
0
10
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
1.4
—
2533.8
—
0
10
(3028308) Erythrocytes [#/volume] in Pleural fluid
46
421
1.09
0.21
1.2
1.5
e6/l
145196.7
69738.9
0.27
29
254
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.5
—
32.0
—
0
7
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
11541.6
—
0
5
(37019676) Renin [Units/volume] in Plasma --supine
0
14
0.00
0.20
0.0
1.0
—
20.5
—
0
8
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
12
99
1.21
0.19
1.5
1.4
%
18.8
26.0
0.49
12
77
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
53
1.13
0.18
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
65
608
1.07
0.18
1.1
1.1
—
3.9
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
153
0.85
0.18
1.3
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
67
0.75
0.17
2.6
2.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
32
292
1.10
0.16
1.1
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
8
72
1.11
0.16
1.1
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1482
14685
1.01
0.15
4.4
4.4
ug/l
2.7
2.8
0.10
1347
13290
(3020491) Glucose [Moles/volume] in Blood
40
372
1.08
0.14
2.2
1.8
mmol/l
7.7
6.4
1.45
32
264
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
26
285
0.91
0.14
1.0
1.0
ng/l
36.0
47.1
1.14
20
198
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
14
160
0.87
0.14
1.1
1.2
%
—
10.9
—
0
20
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
11
94
1.17
0.13
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
23
209
1.10
0.13
1.3
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
33
306
1.08
0.12
4.2
6.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
196
2012
0.97
0.12
2.1
3.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
26
283
0.92
0.12
1.0
1.0
ng/l
800.9
746.7
0.30
20
198
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
19
171
1.11
0.12
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
134
1383
0.97
0.12
1.9
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
35
375
0.93
0.12
1.4
2.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
85
816
1.04
0.12
1.3
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
15
133
1.13
0.12
2.3
2.1
—
—
—
0
0
(4133840)
18
162
1.11
0.11
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
104
1004
1.04
0.11
4.6
3.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
52
548
0.95
0.11
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
75
782
0.96
0.11
1.1
1.1
u/ml
0.3
0.4
0.26
16
170
(3021387) Prolactin [Units/volume] in Serum or Plasma
239
2344
1.02
0.10
1.6
1.6
mu/l
289.9
293.3
0.07
217
2122
(3014599) Egg white IgE Ab [Units/volume] in Serum
40
378
1.06
0.10
1.0
1.1
u/ml
0.8
3.8
0.95
18
95
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
22
203
1.08
0.09
1.3
1.1
ng/l
178.6
399.6
—
8
52
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5002
50102
0.99
0.09
4.2
4.0
mmol/l
1.4
1.4
0.01
4677
46925
(3029396) Erythrocyte agglutination [Presence] in Blood
15
165
0.91
0.08
2.8
2.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
40
420
0.95
0.08
1.4
1.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
63
0.79
0.08
1.2
3.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
84
815
1.03
0.08
4.7
5.5
umol/l
341.1
372.2
1.16
74
710
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
148
1511
0.98
0.08
1.6
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
98
1.12
0.07
2.1
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
9
85
1.06
0.07
1.7
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
102
997
1.02
0.06
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5101
51070
0.99
0.06
4.6
4.4
mmol/l
2.7
2.8
12.71
4757
47729
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
95
928
1.02
0.06
1.4
1.3
u/l
25.2
23.6
0.20
76
777
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
105
0.86
0.06
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
364
3603
1.01
0.06
1.8
1.9
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
39
375
1.04
0.05
1.1
1.2
—
1.5
—
0
25
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
460
4563
1.01
0.05
1.9
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4836
48312
1.00
0.04
4.3
4.1
mmol/l
5.9
5.8
0.81
4452
44671
(3019832) Treponema pallidum Ab [Presence] in Serum
663
6594
1.01
0.04
1.7
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
42
407
1.03
0.04
1.3
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
38
392
0.97
0.04
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
121
1.07
0.03
1.0
1.3
—
—
—
0
0
(4094501)
132
1305
1.01
0.03
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
88
868
1.01
0.02
1.1
1.1
u/ml
5.0
4.7
0.05
32
356
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
379
3772
1.01
0.02
1.2
1.2
iu/ml
90.9
156.8
4.26
140
1405
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
22
213
1.03
0.01
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
250
2491
1.00
0.01
1.1
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
11
104
1.06
0.01
1.5
1.3
mu/l
22.8
124.7
—
6
83
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
114
1.05
0.00
1.3
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
15
148
1.01
0.00
2.1
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
188
1.01
0.00
2.2
2.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
17
165
1.03
0.00
1.9
2.7
umol/l
29.1
29.3
0.04
12
114
(4034850)
159
1595
1.00
0.00
13.7
8.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
184
0.98
0.00
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
20
204
0.98
0.00
2.2
2.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
93
934
1.00
0.00
1.1
1.1
u/ml
1.4
3.2
2.62
30
373
(40758292) HTLV I+II Ab panel - Serum
10
101
0.99
0.00
1.2
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
32
319
1.00
0.00
1.3
1.4
mmol/l
5.6
5.6
0.13
27
302
(3045788) Cell count panel - Pleural fluid
38
379
1.00
0.00
1.2
1.5
—
—
—
0
0
(4038314)
6
61
0.98
0.00
1.2
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
59
1.02
0.00
1.3
1.3
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
65
0.92
0.00
1.7
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
6.8
3.1
umol/l
24.5
45.9
—
6
56
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
59
0.85
0.00
2.4
1.7
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
38.6
—
0
5
(3002853) Influenza virus B Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint ULCERNAS and mortality.

Females

Parameter HR [95% CI] p-value
ULCERNAS 1.597 [1.45, 1.77] < 0.001
Birth year 0.995 [0.99, 1.0] 0.247

During the follow-up period (1.1.1998 — 31.12.2019), 2327 out of 15730 females with ULCERNAS died.

Males

Parameter HR [95% CI] p-value
ULCERNAS 1.456 [1.32, 1.61] < 0.001
Birth year 0.988 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 2658 out of 16249 males with ULCERNAS died.

Mortality risk

Mortality risk for people of age

years, who have ULCERNAS.

N-year risk Females Males
1 0.175% 0.252%
5 0.941% 1.907%
10 2.591% 4.763%
15 4.499% 8.669%
20 7.657% 14.063%

Relationships between endpoints

Index endpoint: ULCERNAS – Ulcerative colitis, NAS

GWS hits: 36

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data